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CHAPTER I 
 
INTRODUCTION 
 
“Progress in science depends on new techniques, new discoveries, and 
new ideas, probably in that order of decreasing importance.”1                                       
-Sydney Brenner (2002 Nobel co-laureate in Physiology or Medicine) 
 
The development of new techniques that increase our knowledge of both normative 
biological metabolism at the cellular level, and metabolic deviation in the event of disease, is 
crucial to the advancement of biology.  New techniques, in turn, often rely upon innovations in 
instrumentation to facilitate their development,1  especially when existing instrumentation for 
whatever reason is inadequate to perform the measurements demanded by the technique.  Of all 
the current fields of novel biological research, the emerging field of metabolomics, defined as the 
”systematic study of the unique chemical fingerprints that specific cellular processes leave 
behind,”2 is expected to be the most predictive of the overall phenotype of an organism,3,4 and 
thus the best suited for use in the diagnosis of disease and detection of metabolic dysfunction.5  
Therefore the development of instruments, and new instrumental techniques, that are capable of 
probing metabolic activities on the cellular level is critical to the advancement of metabolomics 
and with it our understanding of cellular biology.3  
In the past hundred years, thanks to a myriad of research efforts, cellular biochemical 
pathways have been painstakingly mapped out.  The individual components of these pathways, 
including enzymes, substrates, intermediates and products, are now more completely understood 
than nearly any other aspect of biology.6  The available studies, however, present a fragmented 
view of the totality of cellular metabolism.  Since each study focused on an individual enzyme or 
pathway, we are left with a patchwork of individual snapshots that have been aggregated to form 
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a collage of the entire cellular biochemical pathway.  What is missing in this aggregate are the 
quantitative relationships between the individual metabolites of different pathways that, if known, 
could lead to a better understanding about the balance of differing, and sometimes competing, 
processes present in a healthy metabolism.  This, in turn, would allow the better determination of 
the extent and type of metabolic dysfunction in diseased organisms.  In short, the dynamic aspects 
of metabolism, and therefore of cellular biology, simply cannot be understood without an in-
depth knowledge of not only the type, but also the relative quantities of metabolites and metabolic 
precursors that exist, and the conditions under which they are present, in both healthy and 
diseased states of living cells and organisms.7,8   
By studying individual metabolites and their relationships with respect to a particular 
disease we can find specific compounds, known as biomarkers, that could be used to detect the 
presence of, or estimate the extent of, a specific disease.  One such example is the discovery of 
the linkage between the presence of the protein troponin-I (tn-I) in the bloodstream and cardiac 
muscle damage.  While tn-I is present in healthy cardiac muscle, in the event of muscle damage, 
as in a myocardial infarction (heart attack), tn-I is released into the blood stream by cardiac 
necrosis.9   Since tn-I is specific to cardiac tissue the detection of tn-I in the blood stream, done 
via immunoassay10,11 or fluorometric analysis,12,13  is then specifically indicative of cardiac 
damage, and therefore now used as the definitive diagnosis of myocardial infarction.  
Additionally, other research is currently underway to determine new cardiovascular-specific 
biomarkers and pathways in order to detect the presence of myocardial damage, such as cardiac 
myopathy, before the damage becomes irreversible.14  
Although the core cause of most diseases are tied to faulty enzyme activity, improper 
substrate balance, or faulty metabolic regulation, the net result of all these things is a perturbation 
of cellular metabolism.6  Additionally, the fact that metabolic disorders such as atherosclerosis, 
obesity, hypertension, and diabetes are increasingly seen as being epidemic in the population,15  
3 
 
has recently led to an increasing emphasis on the adaptation of technology toward the 
investigation of the intricacies of metabolism.  Just as a project was undertaken to sequence the 
entirety of genes in human DNA, known now as the ‘genome’, the desire for a similar inventory 
of metabolites present within and surrounding cells, called the ‘metabolome’, is being focused 
under the newly founded field of metabolomics/metabonomics.5,16,17  Metabolomics, even though 
a new field, could enable the discovery of new signaling pathways and new areas of research 
building upon what is already known about cellular biochemical pathways.18 
While the first objective of the genome project was a mapping of all of the genes within 
human DNA, the initial goal of metabolomics is to obtain an inventory of all or a substantial 
fraction of metabolites present in a biological sample, and to quantify each individual metabolite 
with respect to an absolute index of the sample (per gram, milliliter, or cell).6,7  Since an 
immediate consequence of a diseased state in an organism is a perturbation of metabolic activity, 
it follows that changes in the relative quantities of both metabolic precursors and metabolites 
would occur as well.  If an accounting were made of all such compounds present in the healthy 
state of an organism, the detection of that perturbation would be a valuable tool in and of itself in 
the diagnosis of disease. 
  The completion of a metabolic inventory may prove to be far more difficult than the 
genome project, however, because unlike DNA, metabolites have a wide distribution of 
molecular compositions and physical properties.6  Analysis of metabolites en masse is typically 
performed by NMR spectroscopy or capillary electrophoresis-mass spectrometry of body fluids 
(e.g., blood or urine),5,19-21 allowing the deconvolution of metabolic events which occur on a 
different temporal scale. 22,23  The primary advantage of these techniques is the measurement of 
multiple analytes simultaneously.  The drawback, however, is that the convolution of the signals 
generated requires intricate computer analyses,19  and individual analyte targeting is extremely 
difficult if not impossible without the addition of extraneous tags to individual metabolic 
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markers.24,25 Another problem is that these instruments are only capable of offering ex-situ 
analyses of the metabolites, and thus while enabling temporal resolution of the metabolic 
activities, they are unable to offer results in real-time.24  In any event, bulk analysis of all 
components of the metabolome, either qualitatively or quantitatively, is beyond the scope of the 
work presented here.   
   In the study of cellular metabolism, another key aspect is the utilization of non-invasive 
means of measurement.  Since the aim of the experiment is to detect and observe minute changes 
in physiological metabolic activity, it is an absolute imperative that the act of performing the 
measurement itself does not make unrecognized changes of its own in the metabolic activity 
under study.  Therefore, in order to draw meaningful conclusions from any data gathered, one 
must be able to say with a high degree of certainty that any changes observed are due to 
metabolic agent activity, or the presence of disease, rather than the presence of, or in response to, 
the analytical equipment, or chemical substances added while performing the measurement.   
The 2008 Nobel prize for chemistry was awarded for the discovery and development of 
green fluorescent protein (GFP), due to the contributions of its wide spread use as a fluorescent 
tag in cell experiments.  It has been found, however, that the addition of GFP as a chimeric tag to 
a protein will actually alter the normative cellular response to that protein.26  Another frequently 
used method is the addition of epitope tags, which are utilized in conjugation with enzyme linked 
immunosorbent assays (ELISA).  One of the most frequently utilized epitope tags is 
hemagglutinin (HA), which is a naturally occurring surface protein from the influenza virus.  Like 
GFP, however, HA tagging has been shown to alter cellular metabolism.27-29  Even the addition of 
a simple six amino acid residue tag has been shown to affect cellular enzyme processing.30  While 
the added effect of these extraneous tags can sometimes be compensated for by comparison to the 
activity of their wild-type cousins, this adds yet another experimental step to an already complex 
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analysis.  Clearly what is needed is an instrumental technique that is neither physically invasive 
nor requisite on the addition of deleterious compounds to perform analyses. 
Since living organisms are not static systems, the ability of a measurement technique to 
render measurement of dynamic cellular processes in real-time is also highly desirable.31,32  
Cellular biology provides multiple control points, signal cascades and feedback mechanisms with 
which to respond to changes in both internal and external stimuli.  The biological response to any 
specific metabolic agent is often not as simple as a switch to a “high” or “low” level of a specific 
metabolite or metabolic rate.  One example is the biphasic release of insulin from β-cells in 
response to a spike in blood glucose levels, in which an initial short burst of insulin is followed 
by a sustained slow release.  This subtle, temporally dynamic response would not be possible to 
observe if it were not for real-time methods of analysis.  While it would be possible to 
quantitatively determine the amount of insulin released with ex-situ measurements it would not be 
possible to ascertain the manner in which it was released, and thus the mechanism governing the 
response would remain elusive.  Additionally, since metabolomics focuses on the balance of 
various metabolites in relationship to changes in metabolic activity, the instrument should allow 
multi-analyte detection capabilities. 
While live cell studies of metabolic activity currently focus on large numbers of cultured 
cells, those studies are irreconcilably limited to data that is also averaged over a large number of 
cells.   It is rapidly becoming clear that even within a given phenotype there is considerable 
variability of metabolic activity from cell to cell.  It may be adequate to utilize an averaged 
cellular response to detect, or diagnose, a particular disease or metabolic dysfunction, however in 
order to understand the actual mechanism behind the disease itself we must understand such 
activities on a single cell level.  For this reason, investigations of large numbers of cells must be 
coupled with single-cell analyses, in order to better determine the statistical variability normally 
present in a population of healthy cells.  This requires instrumental methods that both have 
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sufficient sensitivity to detect the shifts in metabolic activity of a single live cell, and that will 
allow miniaturization to the scale where those measurements may be performed. 
In summation, the field of metabolomics requires methods of investigation that allow 
multiple analytes to monitored in-situ, non-invasively in real-time and by a platform that can be 
scaled toward single cell analyses when required.  One method that is capable of meeting all these 
requirements is electrochemistry.  Electrochemical measurements can be performed non-
invasively, and for metabolites that are electrochemically active, or those that can be detected 
with chemically-modified electrodes, electrochemical measurements provide a relatively 
simplistic and rapid means with which to perform metabolic analyses.  For example, the most 
frequent analytical chemical measurement today, the testing of blood glucose, is neither 
performed in a lab nor by trained technicians.  Rather the testing of blood glucose levels, which is 
required daily to monitor the glucose homeostasis of Diabetes patients, is almost exclusively 
performed electrochemically by the patients themselves, using a glucose sensitive sensor in 
conjunction with a mass produced, hand-held instrument.  Furthermore, when coupling 
electrochemical sensors with a microfluidic design, the resulting instrumentation has the 
demonstrated capability of in situ analyses for tissues and live cultured cells.32   Additionally, 
electrochemistry is able to provide real-time measurement of dynamic processes, including 
simultaneous detection of multiple analytes.  In some cases electrochemical instrumentation can 
be designed on such a scale as to allow for portability of the entire instrument, which presents the 
possibility of bringing the means of analysis to the subject rather than the other way around.  
Furthermore electrochemistry is capable of utilizing extremely small sensor designs that have 
extremely high sensitivity, and in specific cases have been shown to be able to perform single-
molecule detection.33  
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CHAPTER II 
 
BACKGROUND 
 
Sensors 
 Electrochemical sensors have a long history in the measurement of key metabolic 
biomarkers.  The current state of the art in electrochemical metabolic investigation includes many 
macro scale sensors.  The desire to extend metabolomic studies to the single cell level, however, 
demands that these sensors be adapted to the ultramicro scale, or new sensors be designed and 
implemented to allow single cell metabolic studies to be performed.  In the work presented here, 
several electrochemical sensors  were utilized to follow changes in metabolic activity, including 
chemically modified sensors and enzyme modified electrodes on both the macro and ultramicro 
scale. 
 
Oxygen sensors 
One of the most elementary electrochemical assays is the reduction of dissolved oxygen, 
first observed by Ludwig Danneel in 18971 and later encountered by Heyrovsky in his 
development of polarography.2  Initial biological studies were underway as early as 1933 and 
reported by Baumberger in his “Apparatus for the study of reduction-oxidation potential in 
biological systems.”3  The studies utilized the dropping mercury electrode, and in the following 
years he established the ability to measure dissolved oxygen4,5 and applied it to the study of the 
respiratory activity of live yeast cells.6  Baumberger also coupled his electrochemical analysis 
with a study of heat production to generate one of the first metabolic studies of respiration and 
glucose metabolism of live cells.7  There were problems with the use of mercury electrodes and 
biological systems however, including toxicity,  the variation in the size of mercury droplets (in 
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the case of early dropping mercury electrodes) and protein contamination of the mercury itself (in 
the case of a static mercury electrode).8 In 1948, Davies and Brenk were the first to utilize a Pt 
cathode,9 which was mounted in a saline-filled glass capillary with an agar plug to minimize 
contamination (Fig. 2.1a).  While this was more successful than Baumberger’s previous attempts, 
there were still problems with long-term stability due to fouling of the electrode surface.   
 
 
Figure 2.1;  (a) shows the oxygen sensor of Davies and Brenk, which used an agar plug to prevent fouling, (b) 
shows the Clark oxygen electrode, which first utilized a cellophane membrane, and later a hydrophobic 
membrane to prevent biofouling of the Pt sensing electrode. [adapted from Silver]8 
 
To eliminate fouling in 1953 Leland Clark proposed isolation of the Pt electrode behind a 
gas permeable cellophane membrane10,11 in order to measure oxygen saturation in human blood 
during early human total heart bypass surgeries.  While this reduced bio-fouling, the cellophane 
membrane was water, as well as gas, permeable, which continued to allow some proteins to come 
into contact with the electrode surface.  Finally, in 1956, Clark improved his design by replacing 
the cellophane with a hydrophobic membrane (now universally known as the Clark oxygen 
electrode, Fig. 2.1b),12  which addressed the bio-fouling problem more completely.  The electrode 
design, featuring a hydrophobic membrane, is still in use today, more than a half century after its 
initial publication.  Later studies by Clark included continual patient oxygen monitoring,13 the use 
of pyrolitic graphite electrodes for biological oxygen measurement,14 and the design of portable 
solid-state amplifiers for his instrumentation.15 The Clark oxygen electrode continues to be used 
to this day, with little or no modifications beyond those presented in his 1956 paper.12  More 
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recently, the application of a hydrophobic film of Nafion® to a bare Pt electrode16,17 has permitted 
oxygen sensors to be incorporated into smaller instrumental platforms.  While later cathodes in 
Clark electrodes were actually quite small, due to the incorporation of the reference half-cell 
within the electrode enclosure (Fig. 2.1b), the entire sensor assembly is considerably more bulky.  
Application of the hydrophobic membrane directly to the Pt surface allows separation of the two 
electrochemical half-cells, without minimizing prevention of biofouling, and allows for smaller 
sensor designs, including applications in scanning probe techniques.  Although these are not 
Clark electrodes per se, they are designed around the key elements of the Clark oxygen electrode; 
a Pt cathode and a hydrophobic membrane to minimize biofouling. 
The use of the Clark oxygen electrode for monitoring patient arterial blood oxygen levels 
has been almost completely supplanted by the introduction of non-invasive fingertip 
spectrophotometric oximeters.18  Fingertip oximeters are capable of providing continual, real-time 
monitoring of the oxygen saturation in a patient’s blood utilizing only a single fiber-optic probe 
in contact with the exterior of the patient’s fingertip.  The arterial blood oxygen saturation is then 
detected by measuring the fluctuations in light intensity due to the pulsatile flow of blood into the 
fingertip.  In this way the transmitted light can be corrected for the absorption by the muscle and 
tissue portions of the fingertip (which is of a constant nature).  While spectrophotometry is the 
currently preferred method of analysis for hospital patients, electrochemistry remains an 
important method of the determination of oxygen respiration rates of single cells19 and tissue,20 
and has  been proposed as a viability assay for islets destined for human transplantation.21  
Similarly, mitochondrial electrochemical respiration measurements have been more recently 
performed, including work presented later here, via multianalyte microphysiometry (MAMP)22-24 
and scanning electrochemical microscopy (SECM).25-35  
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Enzyme-modified electrodes 
 Another tool that finds use in modern electrochemical metabolic measurement, and one 
also introduced by Leland Clark,36  is the enzyme-modified electrode. The introduction of enzyme 
electrodes to metabolic analyses has greatly increased the range of analytes detectable by 
electrochemistry.  Additionally, the exquisite selectivity of enzymes toward their substrate of 
choice brings with it the highest level of specificity.  This is especially critical given the extent of 
possible interferents in the highly complex samples used in metabolic analyses.37   The first 
enzyme electrode was an adaptation of Clark’s previous work with oxygen sensors.  Instead of 
detecting dissolved oxygen, however, the enzyme sensor design utilized the Pt cathode to detect 
H2O2 generated by a peroxidase enzyme sandwiched between two permeable membrane layers, 
which were incorporated in lieu of the oxygen electrode’s external hydrophobic membrane (see 
Fig. 2.1b).  The electrode was designed to measure physiological glucose concentrations in blood, 
in concert with the Clark oxygen electrode, during heart bypass surgery.  The basis for Clark’s 
electrode is identical in principle, but not in design, to the enzyme electrodes presented later in 
this work.  The enzyme utilizes a specific substrate (either lactate or glucose in our case), and in 
the process of substrate conversion generates H2O2 from dissolved oxygen.  The peroxide then 
migrates toward the Pt electrode surface, which is biased at a potential to drive its oxidation, as 
shown in Eq. 2.1.  
   → 2 +  +  2	
 (E° = + 473 mV vs. Ag/AgCl, 3 M KCl)38  (2.1)  
 Alternate possibilities for modified enzyme electrode design include the use of an 
incorporated electrochemical mediator to replace the oxygen/peroxide couple.  One advantage of 
the incorporation of an external mediator is that a lower potential can be used to drive the reaction 
at the electrode, depending on the choice of mediator to incorporate.  There is the added 
possibility, however, of this mediator leeching from the sensor and contaminating the system 
under study.39  Recent state of the art in enzyme electrode systems, however, attempts to 
eliminate the possibility of redox mediator leakage by providing a covalent linkage between the 
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electrode surface, the enzyme itself, and the incorporated mediator.  This concept was originated 
by Heller and coworkers,39 who linked glucose oxidase (GOx) to a hydrogel that incorporated 
Os(4,4’-dimethylbpy)2Cl as a redox mediator.  If there is a problem with the somewhat high 
reduction potential of peroxide, another possibility is to immobilize a second enzyme, such as 
horseradish peroxidase, on the electrode surface.  With the inclusion of horseradish peroxidase, 
electrode potentials can be reduced by some 100 mV.40  In situations where the oxidation 
potential of peroxide has not proven to be problematic, however, the simplest solution is 
generally the best and therefore no external mediator is required. 
 
Insulin detection 
   Due to the rise in the prevalence of diabetes mellitus among the general populace, there 
has been a drastic increase in the number of investigations into the metabolic processes affected 
by diabetes over the past decade, and with it an increased demand for novel techniques to assist 
their research.  Metabolic studies that focus on the mechanisms of islets and diabetes typically 
utilize either an immortalized cultured β cell line, or whole pancreatic islets extracted from mice 
or rats.  The techniques possible for probing triggered insulin release include perfusion 
experiments coupled with ex-situ insulin detection via ELISA, radioimmunoassay, or 
chromatography.41-43  Kennedy’s group has used an electrophoresis-based immunoassay for 
insulin, and fluorescence spectroscopy for detection of the Zn co-factor and intracellular Ca 
levels.44-48  While these methods have suitably low detection limits they either require extended 
periods of time to acquire data via ex-situ analysis, or require the addition of extraneous tags that 
could possibly alter the metabolic activity under study.49-52  The use of direct electrochemical 
oxidation of insulin for a means of detection, on the other hand, avoids these problems and 
additionally allows real-time, in-situ data collection.53-55 
 The first electrochemical study of insulin release utilized 5-hydroxytryptamine (5-HT), 
which can be taken up by β cells and stored within insulin granules.56  When insulin is released 
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by the cells, the 5-HT is released as well.57-59  This technique, however, required preconditioning 
of the islets and lacked direct quantitative correlation between the detected 5-HT levels and 
amount of insulin secreted.  While other investigations have electrochemically targeted the zinc 
cofactor of insulin,60 there have been more recent developments in direct electrochemical 
oxidation of insulin at modified electrode surfaces.  These sensor designs have included 
ruthenium metallodendrimers,61 ruthenium dioxide,45 ruthenium dioxide/cyanoruthenate,45,62 and 
iridium oxide.63  Of these, however, the iridium oxide sensors suffer from pH sensitivity and slow 
transport rates,64 and the ruthenium oxide and metallodendrimer films have mixed oxidation 
states with complex e− transfer kinetics that vary according to the crystal face of the electrode 
surface.65   
While the majority of electrochemical investigations are done using noble metal 
electrodes, biological investigations tend to favor the more biologically friendly carbon-based 
electrodes.66-69  The use of carbon as an electrode material for biological studies dates back to 
Leland Clark’s use of pyrolitic graphite to measure epicardial oxygen concentrations.14  Other 
forms of carbon electrodes have included glassy carbon,67,70 graphite paste,71-73 carbon fibers,74-76 
and most recently carbon nanotubes.77-80  The first carbon nanotube insulin sensor was developed 
by Wang and Musameh,78 and utilized a dimethylformamide (DMF) nanotube dispersion to create 
a film on the electrode, and recently Wang has incorporated ruthenium oxide into his nanotube 
film as well.81  Wang’s nanotube modified sensor, however, was found to have topographical 
inconsistencies caused by clumping of the nanotubes during evaporation of the DMF.54  Salimi 
and coworkers have also recently developed an insulin sensor based on a glassy carbon electrode 
(GCE) modified with guanine and nickel oxide nanoparticles,82 however this sensor lacks the 
ability of carbon nanotubes to prevent biofouling.  Finally, in our labs we have developed an 
insulin sensor based on multiwalled carbon nanotubes and incorporating a small vinyl monomer, 
dihydropyran (DHP), which aids in cohesion and results in a film thin enough to be incorporated 
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in miniaturized sensor designs,53,55 as well as to withstand the shear forces present in a 
microfluidic system.54 
 
 
Figure 2.2;  cyclic voltammograms for (a) macro and (b) ultramicroelectrodes.  In (a) the dashed line shows the 
non-faradaic contribution to the total current measured. In (b) iss shows the steady-state current, and Cd  shows 
the capacitance in both plots. 
 
Ultramicroelectrodes 
As the focus of investigation shifts from tissues and large numbers of cultured cells to 
individual cells, the quantities of targeted analytes become smaller and smaller, as do the currents 
generated during their detection.  As these analytical signals are reduced the double-layer 
capacitance (Cd) of the electrodes, and for macro sized electrodes the non-faradaic currents they 
generate, becomes larger than the analytical signal (Fig. 2.2a), i.e., the faradaic current due to the 
analyte gets ‘buried’ into the background non-faradaic current.    The double-layer capacitance of 
a given electrode is a function of the radius (r) of the disc electrode and the interfacial 
capacitance of the electrolyte (Cd0, typically 10 – 50 µF/cm2),83 shown in Eq. 2.2.    
  =           (2.2)  
Given this equation, for example, decreasing the size of an electrode from 1 mm to 1 µm would 
cause a corresponding decrease in the double-layer capacitance by some six orders of magnitude 
(from approximately 1 µF to 1 pF).  The corresponding reduction in the magnitude of background 
current has led to the design and implementation of smaller electrodes, which are called 
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ultramicroelectrodes (UMEs) if their diameter is smaller than 25 µm.83  Due to their reduced size, 
they have drastically smaller capacitive charging currents (Fig. 2.2b), and thus have a higher 
sensitivity/lower limit of detection.  Another difference between macro and UMEs is the 
relationship between their Faradaic current and diffusion.  In the voltammogram shown in Fig. 
2.2a, for the macro electrode, as the potential is swept, the current climbs initially, then falls off 
due to the reacted mediator blocking diffusion of fresh mediator to the electrode surface.  The 
equivalent voltammogram for the UME (Fig. 2.2b) shows no diffusion limitation.   
The desire to use UMEs in biological investigations, where carbon is often the electrode 
material of choice, has led to the development of the carbon fiber UME.  Carbon fibers are 
typically 5 – 10 µm in diameter and are manufactured by heating threads of polymers, such as 
acrylonitrile/methyl methacrylate, in an anaerobic environment.84  The heating process vaporizes 
most of the non-carbon atoms, and some of the carbon atoms, leaving behind fibers that are 
almost exclusively composed of crystalline carbon.  Because of their small size, carbon fibers can 
be easily incorporated without further modification into UME designs.  Passing the carbon fibers 
through a flame will also burn off some of the carbon, a process known as flame etching, 
allowing smaller electrode tips to be constructed from carbon fibers as well.85,86 
 
Instrumental Platforms 
The work presented here exclusively focuses upon electrochemical methods of analysis 
to study different biological systems, using two different instrumental platforms.  Studies on large 
groups of cultured cells (300,000 – 500,000 in number), and on small groups of pancreatic islets 
(75 – 100), were performed using the MAMP.    Smaller scale experiments were conducted on 
single pancreatic islets, single cultured cells, and analog ion channels in reconstituted bilayer lipid 
membranes (BLMs) using the SECM.   
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Multianalyte microphysiometer  
The MAMP is a microfluidic platform for the electrochemical metabolic profiling of live 
cultured cells.  The MAMP was developed by modifying an existing instrument, known as the 
Cytosensor Microphysiometer® (Molecular Devices, Sunnyvale, CA), which was originally 
released in 1990,87 and has since been discontinued.  The Molecular Devices instrument utilizes a 
light addressable potentiometric sensor (LAPS) to measure changes in the pH of a low-buffered 
media caused by the metabolic activity of the cells entrapped in the device, and was offered in 
either a 4-channel or 8-channel configuration.  Although it was somewhat successful in its 
endeavors, the original instrument is limited in that it is only capable of measuring one 
metabolite, H+.24  While the use of extracellular acidification can be indicative of overall 
metabolic activity, it in no way allows the determination of which particular pathway is targeted 
in the event of a change in metabolic activity.  A schematic of the cell chamber of the device is 
shown in Fig. 2.3.  
 
 
Figure 2.3; Schematic of the Cytosensor Microphysiometer LAPS sensor and sensor head assembly.  The bias 
(Ψ) is applied between the CE in the sensor head and the base of the LAPS silicon, and the photocurrent (Iphoto) 
is measured as a function of applied potential.  The surface of the LAPS in contact with the solution is covered 
with an insulating Si oxynitride coating. 
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The LAPS, like a ChemFET,88 is an insulated semiconductor device that responds to 
changes in polarization at its electrode/electrolyte interface (i.e., surface potential) with a 
corresponding change in the electric field within the semiconductor itself.89  When an appropriate 
bias (Ψ) is applied to the silicon, the majority of charge carriers at the insulator interface are 
depleted.  In this state, a transient photocurrent (Iphoto) can be generated in response to transient 
illumination of the silicon itself, due to the creation of e–/ hole pairs by the incoming photons.  In 
the case of the Cytosensor Microphysiometer®, the LAPS is an n-type doped silicon wafer topped 
with an oxynitride insulating coating.  The oxynitride consists of Si–O and Si–NH2 groups which 
can bind to H+ ions present in solution, giving pH sensitivity to the electrode.   
 
 
Figure 2.4; (a) the Iphoto response as a function of Ψ at three different pH values.  The value for Ψ at the 
inflection point is a function of solution pH.  (b) a plot of inflection point  potentials as a function of pH (log X, 
with X = [H+]) for a series of solutions with pH values  ranging from 2 – 12, illustrating a Nernstian response of 
59 mV/pH unit @ 25 ºC.  [Adapted from Hafeman]89 
 
The instrument utilizes a 3-electrode system, with the counter electrode (CE) directly 
above the LAPS and the reference electrode (RE) located downstream.   In this configuration, Ψ 
is applied between the RE and the LAPS and Iphoto is measured between the LAPS and electrical 
ground (see Fig. 2.3).  Three overlaid voltammograms showing the Iphoto response as a function of 
Ψ  are shown in Fig. 2.4a for solutions with pH values of 4, 7, and 10.  As Ψ is swept (from -100 
mV to + 950 mV) Iphoto decreases.  The inflection point of the decrease in Iphoto is pH dependent, 
and shifts toward more positive potentials as the pH of the solution increases.  The shift in the 
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Iphoto inflection point follows a Nernstian response of 59 mV per pH unit, as shown in the 
calibration plot in Fig. 2.4b, for the pH range of 2 – 12.89  
 
 
Figure 2.5;  A schematic of a single channel of the original Molecular Devices Cytosensor Microphysiometer®, 
showing the media intake, peristaltic pump, debubblers, sensor chamber, and downstream RE  [Adapted from 
Cytosensor Microphysiometer® manual].87 
 
In addition to the LAPS, for each individual channel the instrument contains separate 
solution lines, peristaltic pumps, media debubblers, and separate heater/thermocouple controllers 
for the inline solution and the cell chamber itself (Fig. 2.5).87  This enables multiple different 
experiments to be conducted simultaneously, limited of course by the number of available  
channels on the instrument.  All instrumental functions are controlled by, and data are output to, 
proprietary software run on the Macintosh personal computer platform.  The Cytosensor® also 
incorporates a RE filled internally with 2 M KCl rather than the typical 3 M KCl, in order to 
prevent salt creep frequently encountered with concentrated KCl solutions, and is placed 
downstream from the cell chamber in order to prevent excessive changes in the osmolality of the 
cell media which could be caused by KCl leeching from the electrode.  
While the instrument was successful in the application of pH monitoring as an indicator 
of overall cellular metabolism, the lack of functionality with respect to additional analytes made 
further investigation into the specific modes of metabolic interference problematic.  In order to 
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expand on the capabilities of the device, a series of modifications were  made in our labs for the 
purpose of enabling the simultaneous measurement of multiple analytes.22  A schematic of a 
simplified cellular metabolic pathway is shown in Fig. 2.6.24  This figure depicts a simplified 
model of cellular energy pathways as monitored by four key biomarkers; oxygen, glucose, lactate, 
and H+ production.   Stock Molecular Devices sensor heads were modified to incorporate enzyme 
modified electrodes for lactate oxidase (LOx) and GOx (Pt discs, 0.5 mm), an electrode for 
oxygen determinations (Pt disc, 127 µm), and an additional CE (Pt disc, ~2 mm) to separate 
 
 
Figure 2.6;  A simplified cellular metabolic pathway, showing how the monitoring of four biomarkers (oxygen, 
glucose, lactate, and extracellular acidification) can be used to follow changes in the metabolic activity of a live 
cell [Adapted from Eklund].22 
 
cross-talk caused by the simultaneous operation of amperometric and LAPS sensors.22-24,90  A 
photo of a modified sensor head is shown in Fig. 2.7.  A dedicated multipotentiostat was also 
designed and implemented to allow simultaneous collection of amperometric signals in the 
instrument’s 4 or 8-channel configurations.  
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Figure 2.7;  A modified Molecular Devices sensor head.  The added electrodes include (A) a 2 mm Pt CE, (B) 127 
µm Pt disc for oxygen, (C,D) 0.5 mm Pt discs for GOx and LOx electrodes.  
 
The detection of glucose, lactate, and oxygen are accomplished via amperometry.  Of the 
three only the detection of oxygen is done via direct reduction; at a Pt disc coated with Nafion® 
which acts as a barrier to biofouling.  The resulting reaction at the electrode surface is most likely 
a 4 proton, 4 e− process, as shown in equation 2.3.83 
 +  4 +  4	
 → 2  (E° = − 500 mV vs. Ag/AgCl, 3 M KCl)   (2.3) 
Glucose and lactate detection is performed indirectly via enzyme modified electrodes, using GOx 
and LOx respectively.  Since both enzymes produce H2O2, which is detected at the Pt disc 
electrode, they share the same potential bias.  The detection is indirect in that the electrode senses 
the H2O2 produced by the enzyme, and not the substrate itself.  The enzyme catalyzed reactions in 
the case of GOx and LOx respectively, and for electrochemical oxidation of hydrogen peroxide at 
the Pt electrode are the following:83 
  − 	 +    
   −  !" 	 +    (2.4) 
 # − !"!"	 +   
$  %&'!"	 +     (2.5) 
   → 2 +  +  2	
 (E° = + 473 mV vs. Ag/AgCl, 3 M KCl)38  (2.6) 
The sensors are constructed by hand casting an aqueous gel matrix consisting of the enzyme, 
bovine serum albumin (BSA), and glutaraldehyde as a crosslinking agent onto their respective Pt 
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electrodes.  A Nafion® layer may also be optionally added to the glucose oxidase film to prevent 
biofouling of the electrode.  
All experiments performed in the MAMP, and in the Cytosensor Microphysiometer® as 
well, are done using a flow/stop-flow protocol that allows measurements to be performed in the 
absence of convection within the cell chamber.  The general protocol utilizes 80 seconds of flow 
followed by 40 seconds of quiescence (stop-flow) while the measurements are being recorded.  
This also allows the buildup of cellular products and the greater depletion of glucose and oxygen 
due to metabolic activity, increasing the effective sensitivity of the electrodes over what would be 
possible in a continuous flow mode.  This can be seen in Fig. 2.8 (solid line),53 which depicts the 
response of a GOx electrode.  At the initiation of the stop-flow (t = 0 s), the peristaltic pump cuts 
off and the supply of fresh glucose is stopped.  During the stop-flow, the current decreases due to 
 
 
Figure 2.8;  The response of a GOx enzyme electrode during a stop-flow cycle in the presence of live cells (solid 
line) and after the cells have been killed with alamethicin (dashed line).53 
 
depletion of the solution glucose by both the processes at the enzyme electrode and to the cellular 
metabolism itself.  At the end of the stop-flow (t = 40 s), the pump turns on, and the glucose in 
the chamber is replenished.  In order to eliminate external factors (such as depletion of analyte by 
the electrode) from calculations of cellular metabolic rates, at the end of the experiment the cells 
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are killed by addition of alamethicin, a peptaibol antibiotic that is known to form water channels 
in the outer cell membrane,91-93 to the extracellular media.  The response of the same electrode 
after killing the cells is shown as the dashed line in Fig. 2.8.  The difference between the ‘dead 
cell’ stop-flow peak and the ‘live cell’ peak (∆ip) is then the portion of the Faradaic current that 
can be directly attributed to the metabolic activity of the cells themselves.  Similar calculations 
are performed with the lactate and oxygen electrodes, to ensure that only the portion of the signal 
that can be attributed to the cell’s activity is used to calculate metabolic rates.  After the cells are 
killed, the sensors are then calibrated individually via standard addition to calculate the exact 
sensor response to be used in quantitative calculations. 
 
Scanning electrochemical microscopy 
 SECM is a non-invasive variant of scanning probe microscopy developed by the Bard 
lab in 1989.94,95  Although related to the scanning-tunneling microscope and the atomic force 
microscope, it utilizes non-destructive electrode potentials and operates exclusively in the non-
contact imaging mode using UMEs as imaging tips. The current generated at the UME is a direct 
function of the concentration of the redox mediator and, unlike with macro-scale electrodes, is not 
affected by diffusion of mediator toward or away from the electrode tip.  Because of the 
extremely small size of the electrode, the product diffuses away from the electrode tip as soon as 
it is formed, providing no hindrance to the incoming diffusion of  fresh mediator.  The current 
reaches a stable plateau instead, known as a steady state current (iss).  The value of iss for a disc 
UME, at an infinite distance from a substrate (iss,∞), is given by Eq. 2.7.83 
 ()),+ = 4 ,!      (2.7) 
In the Eq. (2.7) n is the number of e− transferred in the reaction, F is Faraday’s constant (96,485 
C mole-1), D is the diffusion coefficient of the redox species (cm2 s-1), C is the concentration of 
the redox species in solution (mole·cm3), and a is the radius of the UME’s conductive tip (cm).  
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Using equation (2.7) at a 5 µm electrode (a = 2.5 µm) for a 1 mM solution of ferrocene (D = 1.70 
× 10-05 cm2 s-1),96 n = 1 and we would expect the following current: 
())(+) = 4(1) 096,485 56789  : 01.70 × 10

? @6A
B : (10

C 6789
@6D )(2.5 × 10

Ecm) = 1.6 nA (2.8)  
The current as the tip approaches a substrate will change, however, and it is this change that 
permits what Bard has termed the concept of ‘feedback current imaging’.95  This concept depends 
on the Faradaic current of a redox mediator and the diffusion of that mediator to and from the tip 
of an UME (Fig. 2.9a).65   There are two different possibilities for the type of feedback one might 
experience during an SECM experiment when the UME tip is near a substrate.  Positive feedback 
occurs between an UME and a conducting substrate (Fig. 2.9b). The redox mediator (O) diffuses  
 
 
Figure 2.9;  (a) the diffusion of the oxidized form of a redox mediator (O) to the biased tip of an UME where it 
gains an electron, converting it to the reduced form (R) and then diffuses away again.  (b) the concept of positive 
feedback over a conductive substrate.  (O) diffuses to the UME tip, where it gains an electron converting it to 
(R), which can diffuse to the conductive substrate and be regenerated as (O).  This creates a positive feedback 
loop, increasing the faradaic current as the UME approaches the substrate.  (c) the concept of negative feedback, 
where an insulating substrate blocks the flow of (O) to the electrode surface, limiting the extent of the reaction, 
and thus the Faradaic current generated  [Adapted from Nagy].65 
 
to the tip, which is biased at a potential that converts the mediator to its reduced form (R).  The 
conductive substrate, if properly biased, can then regenerate (R) to its original form as (O) via 
oxidation.  The extent of regeneration, and thus the magnitude of current generated, depends upon 
the distance between the UME tip and the substrate.  Negative feedback occurs in the event the 
24 
 
UME is close to an insulating substrate (Fig. 2.9c).  The mediator (O) diffuses to the tip, which 
like the previous case is biased, driving its conversion to (R).  When the UME is in close 
proximity to the substrate, however, there is a restriction in the flow of (O) to the UME tip, 
creating a diffusional hinderance that effectively reduces the Faradaic current. Additionally,  
since the substrate is not conductive it can not drive the reverse reaction, and (R) will simply 
diffuse into the bulk of the solution.  The combined effects of the diffusional hinderance and lack 
of mediator recycling leads to a dramatic decrease in current as the UME tip approaches the 
substrate surface.  
 
 
Figure 2.10;  The faradaic current passed as an UME approaches a conductive substrate (solid line) and an 
insulating substrate (dashed line) [adapted from Nagy].65 
 
The ability of both positive feedback and negative feedback to produce images can be 
shown by observing how the Faradaic current changes as the tip approaches each type of 
substrate (Fig 2.10).94  As the UME approaches a conductive substrate (solid line), the extent of 
redox mediator that reaches the substrate for regeneration increases, while the distance it must 
travel between the two is reduced, creating a feedback effect.  This positive feedback loop then 
causes a nearly exponential increase in  Faradaic current  as the  UME approaches  to  within one 
tip diameter of the substrate.  In the case of an insulating substrate, as the UME gets closer and 
closer to the substrate, there is an increasing blockage of the diffusion of unreacted redox 
mediator to the tip, resulting in a drastic decrease in measured Faradaic current at the UME tip.  
In either case, the Faradaic tip current (itip) is a function of the UME to substrate distance, and 
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therefore the current can be recorded and used to create a topographical image.  In order to 
generate an SECM image, the tip is scanned in a raster pattern in the X and Y dimensions while  
maintaining a constant Z-axis position (i.e., constant height mode), using either piezo-electric 
inchworm motors, or precision stepper motors (Fig 2.11).  While the tip is being scanned, the 
current is recorded as a function of its position in the X-Y plane.  
 
 
Figure 2.11;  Schematic of the inchworm piezo stage of the commercial available CH Instruments SECM.  Each 
axis is controlled by an individual inchworm. The x- and y-axis inchworms are connected to a sliding translation 
stage, while the z-axis is connected to the UME via a probe mount [adapted from Bard].83 
 
Additionally, SECM imaging may be accomplished in either constant height or constant 
distance modes, depending on the capabilities of the instrument (Fig. 2.12).  First generation 
SECM instruments, including those used for the work presented here, are capable of only 
constant height imaging.  In this imaging mode the UME tip is held at a constant position 
vertically while rastering horizontally in the x-y plane to collect data (the solid line in Fig. 2.12).  
No matter the variation in topography, the z-axis position of the UME probe will not change.  
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Since the current signal is dependent on the tip-surface distance, image resolution will suffer in 
areas where the surface being imaged is farther from the UME tip (area shaded red in Fig. 2.12).   
The addition of a z-axis feedback loop to the instrument, present in second generation SECM 
instruments, allows the z-axis tip-substrate distance to remain constant (dotted line in Fig. 2.12).  
This allows the tip to be maintained at the ideal distance from the substrate (1–2 tip diameters)97 
for maximum image resolution (area shaded yellow in Fig. 2.12).    In this imaging mode, 
topographical and chemical data may be collected simultaneously by recording the UME z-axis 
tip deflection along with tip current.  There are differing methods to accomplish constant distance 
imaging, including constant current mode,97 dampening of tip modulation,98 and monitoring AC 
tip impedance.99-101 
 
 
Figure 2.12;  Constant height vs. constant distance imaging modes.  In constant height mode (solid line), the z-
axis position of the UME is fixed.  In constant distance mode (dotted line), the z-axis distance is constantly 
modulated to maintain a constant tip-substrate distance.  Since the signal generated in imaging is distance 
dependant, it is critical to maintain tip-substrate separation within 1-2 tip diameters (yellow shaded area).  
When that tip distance is exceeded in constant height mode (red shaded area), image resolution will suffer. 
 
 Although the SECM was initially applied to biological investigations soon after being 
introduced,102 more recent investigations have led to specialized instrumental configurations for 
biological investigations, termed biological scanning electrochemical microscopes (Bio-
SECM).101  Under most circumstances, in biological applications topographical imaging is always 
performed in the negative feedback mode due to the insulating nature of biological surfaces.  
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Topographical imaging, however, is neither the only nor the most useful aspect of Bio-SECM.  
Another, more biologically relevant, feature of Bio-SECM is accomplished via generation-
collection (GC) mode97 (Fig. 2.13).  In this technique, a redox molecule or biomarker is generated  
 
 
Figure 2.13;  GC-imaging mode utilizes a substance generated at the substrate.  In the case of biological imaging, 
the substance may either be (a) produced by the cell or (b) consumed by the cell. 
 
by the substrate or in our case the biological entity (red plume in Fig 2.13), and collected at the 
UME tip via an electrochemical reaction.  This produces a diffusional gradient, with the highest 
concentration at the source of production.103  Alternately, if the biological subject is consuming 
the substance instead of generating it an inverse diffusional gradient will be seen, with the 
maximum concentration in the bulk solution and the minimum concentration at the point of 
uptake (not shown).  In the case of oxygen respiration, where the oxygen molecules freely diffuse 
through the entire cell membrane, a uniform area of depletion is seen surrounding the cell.25,30,104  
The GC imaging mode therefore allows monitoring of actual biological processes in real-time, 
and therefore generation of spatio-temporal maps of biological activity across the surface of a 
live cell or organism.  
The adaptation of Bio-SECM to metabolomic studies will allow a critical jump to be 
made from the macro scale to the ultramicro scale.  Previous methods like GC/MS, NMR, or even 
MAMP all are limited in their sensitivities, as well as their ability to track metabolic changes in 
real time.  While more than adequate to study tissue samples, or even large numbers of cultured 
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cells, these techniques lack the ability to be employed in the investigation of single-cell metabolic 
studies.  While it is true that in vivo cells are constantly in contact with other cells via messaging, 
the ability to understand what happens on the single cell level is critical to understanding the 
inner mechanisms of cellular metabolism, and determining the extent of variations in metabolic 
activity within individual cellular phenotypes.  Also in addition to increased sensitivity, the Bio-
SECM promises the ability to study biochemical activity on a spatial as well as temporal scale. 
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CHAPTER III 
 
ORGANOPHOSPHATE TOXICITY STUDIES VIA MULTIANALYTE 
MICROPHYSIOMETRY * 
 
Due to the relationship between the health of an organism and a balanced metabolism, 
individual elements (i.e., metabolic precursors or products) of the biological metabolic pathway 
(e.g., biomarkers) can be utilized to study, detect, and diagnose diseases and metabolic 
disorders.1-5  In addition to dysfunctions originating from live pathogens, such as a virus or 
bacteria, metabolic profiling can also be utilized to detect the presence of, or study the effects of, 
a chemical toxin.6-10  The techniques of the emerging field of metabolomics, therefore, with their 
unique focus on the detection of subtle changes in cellular metabolism, are optimally suited for 
this method of investigation.11-16   
 
Background 
 OP toxins are esters of phosphoric acid (Fig. 3.1), with applications including 
insecticides, pesticides, herbicides, and biological nerve agents.  Large dose exposure to OP 
compounds has been shown to rapidly induce neurotoxicity in humans,17-20  and long-term 
exposure to sub-lethal levels  leads to a condition known as neuropathy,21 which is marked by a 
deranged function of neural and motor activity.  While there have been recent studies focusing on 
elucidation of the specific neurochemical pathways implicated in OP toxicity,22,23 the significance 
of these pathways is not yet completely understood.24  Without an in-depth knowledge of the 
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Figure 3.1;  OP compounds are esters of phosphoric acid with three possible substituent groups.  OP compounds 
utilized in these toxicity studies were parathion (R1 and R2 are ethyl, and R3 is paranitrophenyl). 
 
pathways involved, the development of therapeutic agents is currently done via combinatorial 
investigations,25-27 in a more or less trial and error methodology.  This study aims to combine 
experimental measurements and computational analysis of cellular processes in order to better 
understand the mechanism of OP-induced neurotoxicity and to point the way toward 
pharmacological targets for therapeutics/protectants.  
 
 
Figure 3.2; A schematic of the primary and known secondary targets for OP-induced  neurotoxicity. 
 
 OP compounds are known to induce toxicity primarily through inhibition of 
acetylcholinesterase (AChE) in the plasma membrane of neural cells.28-31  AChE itself is a highly 
active enzyme that degrades excess acetylcholine (ACh) present in the synapse.  With AChE 
blocked, excess synaptic ACh rapidly over stimulates both nicotinic (nAChR) and muscarinic 
(mAChR) cholinergic receptors.32-35  In addition to the primary target of AChE, there are multiple 
secondary targets of OP compounds as well36,37 (Fig. 3.2).  Studies utilizing AChE− knockout 
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mice (mice lacking AChE) have shown a higher susceptibility toward OP-induced toxicity in 
mice without AChE,38 strongly suggesting alternate modes of action.  Butyryl cholinesterase 
(BChE), which also works on ACh, has been implicated as a possible secondary target resulting 
in acute OP-induced toxicity.38-40  Additionally, delayed neuropathy is thought to be linked to OP 
action through neuropathy target esterase (NTE), which although associated with the nervous 
system is distinct from AChE.41-44  It is also known that chlorpyrifos (see Fig. 3.1), a specific OP 
compound, acts directly upon multiple components of the adenylyl cyclase cascade,45-48 which 
helps to control intracellular calcium levels via regulation of the production and degradation of 
cAMP.  Chlorpyrifos’ modes of action include direct modulation of adenylyl cyclase activity, 
affecting functions of G-proteins linking neurotransmitters and hormones to cyclase activity, and 
the expression of neurotransmitter receptors acting within the cascade.49,50  
 Stimulation of either nAChR or mAChR will result in an increase in intracellular Ca2+ 
concentration51-53 (Fig. 3.3).  The source of the increase, however, is different for each receptor 
system.  For the nAChR system, stimulation results in an opening of the nicotinic ligand-gated 
ion channel and a subsequent influx of Na+, which depolarizes the cell membrane causing L-type 
voltage-dependent Ca2+ channels to open.54  Conversely mAChR targeting results in activation of 
phospholipase C (PLC) and resulting in the hydrolysis of phosphatidylinositol biphosphate (PIP2) 
to inositol triphosphate (IP3) and diacylglycerol (DAG).55,56  Newly produced IP3 binds to (and 
opens) the IP3-dependent Ca2+ channel located on the endoplasmic reticulum.  This, in turn, 
releases stored Ca2+ which effectively increases the intracellular concentration.  Regardless of the 
mode of action, overstimulation of cholinergic receptors by excess ACh in the cholinergic 
synapse has been shown to disrupt normal cellular calcium function in PC12 cells.57,58 
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Figure 3.3; a graphic depiction of the modes of action of OP-induced neurotoxicity upon nAChR and mAChR. 
 
In neuronal cells normative changes in intracellular Ca2+ concentration drive a diverse set 
of cellular responses, including modulation of the rate of cellular metabolic processes, the 
induction of cellular signaling cascades,  and increases in neurotransmitter release such as 
dopamine,59 GABA, and aspartate.60  When intracellular Ca2+ levels are high for long periods of 
time, however, the cell becomes susceptible to a wide variety of cytotoxic phenomena, including 
“pathological” protein phosphorylation,61 which leads to cell death.62  Other problems with long-
term elevated levels of intracellular Ca2+ include increased calmodulin (CaM) activity,63-65 
sustained protein phosphorylation66 and excessive reactive oxygen species (ROS) formation.62  
ROS, in particular, have been shown to cause mitochondrial damage and impairment of metabolic 
function,67 and excessive ROS formation can lead to caspase-dependent cell death.68  Finally, 
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increased intracellular Ca2+ leads to activation of transcriptional factors through mitogen-
activated protein (MAP) kinase cascades and upregulation of tyrosine hydroxylase activity.69-71  
OP cytotoxicity is also responsible for the release of catecholamines from PC12 cells 
through a prolonged increase in intracellular Ca2+ concentration.59,60  Catecholamines (e.g., 
dopamine) are produced from tyrosine through a series of enzymatic reactions.72-74  Tyrosine is 
converted to 3,4-dihydroxyphenylalanine (DOPA) through the action of tyrosine hydroxylase 
(regulated by PKC, PKA and kinase cascades).69-71  DOPA can then be converted to dopamine 
through the action of DOPA decarboxylase.  Dopamine can be further metabolized to 
norepinephrine.  Once produced, the catecholamines are stored in granules located near the 
plasma membrane.  The release of catecholamines through exocytosis is driven by a 
transmembrane proton gradient created by the activity of an ATPase in the granules.75  
Intracellular Ca2+ catalyzes the granule/cell membrane fusion event by activating the 
Ca2+-dependent soluble N-ethylmaleimide-sensitive fusion (SNARE) complex.76  OP-induced 
release of large quantities of catecholamines increases the extracellular concentration of 
catecholamines, ultimately leading to well-documented long term cytotoxic effects in diseases 
such as Parkinson’s.77 
 
Development of Intracellular Pathway Model 
Once the primary intracellular pathways and processes involved in OP cytotoxicity have 
been identified, the individual pieces of the pathway are coalesced into a quantitative dynamic 
intracellular pathway model. The pathways summarized below focus primarily on the down- 
stream effects of the inhibition of AChE.  Pathway connectivity was fully prescribed for the 
pathways identified during the literature search. 
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Figure 3.4;  Model of Glycolysis pathway [adapted from Lambeth25] 
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Central Carbon Metabolism 
The glycolysis model (Fig. 3.4) used in this work is modeled after the one originally 
proposed by Lambeth.78  It contains validated equations for each enzymatic reaction in central 
carbon metabolism as well as for ATP buffering.  All enzymes are implemented with fully 
reversible kinetic equations, with the reverse Vmax calculated using a Haldane relation.  The 
individual glycogen phosphorylase isozymes A and B are accounted for, which allows for 
inclusion of independent isozyme dependencies on metabolites, such as AMP.  The 
phosphofructokinase (PFK) reaction includes the AMP activation and ATP inhibition observed 
experimentally.  A Cleland Bi-Bi reaction is used for the creatine kinase ATP buffering kinetics.  
Creatine kinase can be inhibited by ATP, ADP, and phosphocreatine, consistent with 
experimental information.  The final model consists of 14 reactions and 21 species.  The 
glycolysis model ultimately takes glycogen and glucose and produces lactate.  However, part of 
the pyruvate produced during glycolysis is transformed into acetyl coenzyme A and sent into the 
mitochondrial TCA cycle.  
A detailed mitochondrial model (Fig. 3.5) was constructed, including oxidative 
phosphorylation and matrix processes. The primary input to the model is acetyl coenzyme-A 
(AcCoA), which is a shared point of convergence for the oxidation of glucose as well as fatty 
acids.  The TCA cycle completes the oxidation of AcCoA to CO2 and produces NADH and 
FADH2, providing the driving force for oxidative phosphorylation.  The respiratory chain 
oxidizes NADH and FADH2.  Pumping protons across the mitochondrial inner membrane 
establishes an electrochemical gradient, or proton motive force (∆µH), composed of an electrical 
gradient (∆Ψm) and a proton gradient (∆pH).  This proton motive force drives the phosphorylation 
of matrix ADP to ATP by the F1F0-ATPase (ATP synthase).  The large ∆Ψm of the inner 
membrane (-150 to -200 mV; matrix negative with respect to the cytoplasm) determines the 
electrochemical transport of ions, including the co-transport of ATP and ADP by the adenine 
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Figure 3.5; Mitochondrial model adapted from Cortassa26.  The concentric circles with an arrow across located 
at the inner mitochondrial membrane represent the inner membrane potential (∆Ψm).  Dotted arrows indicate 
regulatory interactions either positive (arrowhead) or negative (−). 
 
nucleotide translocation, Ca2+ influx via the Ca2+ uniporter, and Ca2+ efflux via the Na+/Ca2+ 
antiporter.  The model also accounts for the explicit dependence of the TCA cycle enzymes 
isocitrate dehydrogenase and α-ketoglutarate dehydrogenase on Ca2+.  In this way, the rate of 
Ca2+ uptake by mitochondria is involved in membrane polarization through the TCA cycle and 
oxidative phosphorylation.  Calcium dynamics are an important part of this model, because the 
primary action of OP compounds is to cause a prolonged increase in cytosolic Ca2+ concentration. 
The final model consists of 27 chemical species and 22 detailed reaction fluxes governed by 
specie inhibition/activation.79 
 
Signaling and Calcium Dynamics 
A summary of the pathways included in the model is shown in Figure 3.6, which includes:80  
• Phospholipase C activation and intracellular calcium release. 
• Protein kinase C activation and MAPK cascade activation. 
• Adenylyl cyclase activation and cAMP production. 
• Phospholipase A2 activation and arachidonic acid production. 
• The inclusion of kinase and phosphatase activation and inactivation for positive and 
negative feedback loops. 
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Figure 3.6; a summary of the complex pathway, showing the major signaling routes. 
 
The model was modified to account for IP3 regulated endoplasmic calcium release and 
extracellular calcium influx.81 Pathways within the signaling model are linked through second 
messengers such as arachidonic acid that are produced in one pathway and used as an input to 
another pathway. An alternative way that pathways are linked is through enzyme activation. 
Enzymes whose activation was regulated by one pathway were coupled to substrates belonging to 
other pathways. The input to the signaling model is the extracellular acetylcholine concentration, 
which activates muscarinic receptors on the cell surface, ultimately leading to the release of 
calcium and activation of protein kinases. The complete pathway used in the model is shown in 
Fig. 3.7. 
 
Experimental 
Materials 
All materials were used without modification unless otherwise noted.  Glassy carbon rods (1 mm 
diameter) were obtained from Structure Probe, Inc. (West Chester, PA).  All microphysiometer 
consumables were purchased from Molecular Devices (Sunnyvale, CA).  PC12 
 
41 
 
 
 
Figure 7 
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cells, Ham’s F12K media, fetal bovine serum (FBS) and horse serum were ordered from the 
American Type Culture Collection (ATCC).  Dulbecco’s phosphate buffered saline (DPBS), 
HEPES, DMSO, and dopamine from Fisher.  Collagen (type IV, from human placenta), 
1,6-hexanedioldiacrylate, parathion, 1,6-hexanedioldiacrylate, potassium tetrakis(4-chlorophenyl) 
borate, Ebecryl 600 (bisphenol A epoxydiacrylate), Uvecryl P36 (copolymerizable benzophenone 
photoinitiator) and 0.5 mm Ag wire were ordered from Sigma-Aldrich.   Calcium bis[4-
(1’,1’,3’,3’-tetramethylbutyl)phenyl] phosphate (CaTBPP) was obtained from Dojindo Molecular 
Technologies, Inc.  ASTM Type I (18 MΩ·cm−1) analytical grade deionized water (DW) was 
obtained with a Solution 2000 Water Purification System from Solution Consultants.   
Electrochemical measurements for calibration and sensitivity testing, the chloridizing of 
the Ca2+ sensor, as well as Ca2+ detection during MAMP experiments, was accomplished using a 
model 660A potentiostat (CH Instruments, Austin, TX), in the included Faraday cage with 
picoamp current booster, and using a standard 3-electrode electrochemical setup.  Experiments 
utilized MAMP sensor heads as WE, commercial macro Ag/AgCl, 3 M KCl RE (CH Instruments 
model CHI111), and Pt mesh or coiled Pt wire CEs fabricated in our lab. 
Ferrocenylmethyltrimethylammonium hexafluorophosphate (FcTMA) was prepared according to 
the method of Mirkin and co-workers.82 
 
Cell Culture and Preparation 
A frozen PC12 cell culture was obtained from ATCC. This culture was thawed, seeded in 
growth medium (Ham's F12K medium with 2 mM L-glutamine adjusted to contain 1.5 g/L 
sodium bicarbonate, 82.5%; horse serum, 15%; fetal bovine serum, 2.5%, hereafter referred to as 
growth media) and placed in an incubator for propagation (5% CO2, 37 ºC).  In order to provide a 
cell repository, a number of cells (equivalent to the original culture) were separated after the 
initial propagation, re-frozen, and stored in vapor-phase liquid nitrogen.  In the event of active 
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cell line contamination or failure to thrive, this repository permits restoration with a minimal loss 
of time.  PC12 cells were grown on sterile dishes and/or cell culture vials coated with collagen 
type-IV (mouse or human) to promote adhesion.  Cells were subcultured every 5-9 days, 
depending upon when confluency was achieved.  Cells cultured in 90 mm dishes had growth 
media changed daily, while those cultured in larger vials necessitated less frequent media change.   
To prepare cells for use in the MAMP, Cytosensor® capsule cups, contained in a 12 well 
plate, were coated with type-IV collagen (to promote PC12 adhesion) from a solution in 0.5% 
acetic acid to achieve a coverage of  5 × 10-6 g cm-2.  The 12 well plate was then loosely covered, 
allowing for ventilation during evaporation, then placed into an oven at 35 °C for 12 – 24 hours, 
or until dry.  The cups were then washed 3x with Dulbecco's phosphate buffered saline (DPBS), 
which was prepared with sterile water, and once with 70% EtOH, and stored at 5 °C until use.   
MAMP experiments were scheduled to coincide with cell culture cycles to retain 
maximal propagation rates from the cells.  During subculturing, excess PC12 cells removed 
during transfer were utilized to seed the type-IV collagen coated Cytosensor® capsule cups.  The 
previously coated capsule cups were removed from refrigeration and allowed to come to room 
temperature, then rinsed 3x with growth media.  The cells were transferred under sterile 
conditions in a ventilated hood, then given fresh growth media and returned to the incubator 
overnight prior to use in the MAMP the following day.  This allows the cells at least 12 hours to 
recover from transfer and to attach to the membrane in the capsule cup.  Shortly prior to insertion 
in the MAMP, the growth media is removed manually via aspiration with a transfer pipette and 
replaced with running media.  The cell cups are then transferred to the MAMP and the cells are 
allowed to re-equilibrate to 37 °C prior to the initiation of measurements.    
 
MAMP Procedure 
The ‘running medium’ contains glucose at an 11 mM concentration and, due to 
atmospheric pressure, oxygen at an equilibrium concentration of 0.24 mM.  The 
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microphysiometer pumps medium into the cell chamber for specified amount of time (tflow), and 
then stops the flow for a certain amount of time (tstop) in order to measure the 
production/depletion of metabolites.   For the purposes of our experiments, tflow  was 2.5 minutes, 
and tstop was 30 seconds.  Due to the limited solubility of OP compounds in aqueous solutions, the 
running medium was supplemented with 2.5% DMSO. 
Initial experiments followed levels of oxygen, lactate, glucose, and cellular H+ 
production, while later experiments replaced the oxygen sensor with  a 1 mm carbon electrode for 
dopamine detection.  The carbon electrodes were coated with Nafion® to minimize signal 
distortion caused by ascorbic acid (AA).  Additionally, a potentiometric Ca2+ sensor was 
incorporated into the existing microphysiometer framework, increasing the number of potential 
biomarkers to six (4 metabolic and 2 signaling).  A flow-cell sensor with a similar geometry was 
identified in the literature,83 and the existing sensor head was modified accordingly.  During 
experimentation, however, it was determined that the crosstalk created by use of three different 
instruments (LAPS potentiostat, MAMP multipotentiostat, and a separate potentiostat for Ca2+ 
determination) in the same microfluidic chamber was too prohibitive for data collection.  For this 
reason, in MAMP channels where Ca2+ measurements were performed no amperometric sensors 
were included.  LAPS measurements for extracellular acidification, however, were performed in 
conjunction with Ca2+ measurements, and only Ca2+ data from cells with equivalent rates of 
extracellular acidification were utilized for analysis.  All potentials reported for MAMP studies 
are vs. the MAMP internal Ag/AgCl, 2 M KCl RE. 
a. Dopamine Measurements 
The detection of dopamine using oxidative amperometry is well-established in the 
neuroscience community.  The preferred electrode material for dopamine detection on the macro 
scale is a GCE.  Calibration of the GCE was performed using a standard solution of 10-4 M 
dopamine in HEPES cell buffer (130 mM NaCl, 10 mM HEPES, 1.5 mM CaCl2, 0.5mM 
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Figure 3.8;  A amperometric calibration plot for the GCE incorporated in the MAMP sensor head, showing 
current as a function of Log (dopamine concentration). 
 
MgSO4, 1.3 mM KH2PO4, 34 mM Dextrose, pH adjusted to 7.4), hereafter referred to only as cell 
buffer. The cell buffer was used to spike a 10.00 ml sample to produce the calibration curve.  The 
addition of 1, 10, 50, 100, 500, and 1000 µL (e.g., 1, 9, 40, 50, 400, and 500 µL successive 
additions) made concentrations of 10-8, 10-7, 5x10-7, 10-6, 5x10-6, and 10-5 M dopamine.  
Measurements were taken via Square-Wave Voltammetry (SWV) with scans from − 0.3 V to 
+ 0.5 V (vs. Ag/AgCl, 3 M KCl RE) taken in 4 mV increments (40 mV amplitude and 50 Hz 
frequency).  Figure 3.8 shows a calibration curve of current (pA) versus Log (Dopamine 
concentration, M) for the range tested.     
b. Calcium Measurements 
The detection of Ca2+ was performed via potentiometry with an ion-selective electrode, 
based on a 0.5 mm Ag disc integrated into the MAMP sensor head assembly.  The sensor was 
adapted from previous work published by Dimitrakopoulos.83  Sensor fabrication began by 
chloridizing the Ag disc in a 100 mM KCl solution by applying a potential of + 0.5 V, vs. 
Ag/AgCl, 3 M KCl RE for 15 – 20  minutes.  The freshly chloridized electrode was then washed 
with copious amounts of DI water.  The chloridized electrode surface was then covered with a 
photo-polymerizable mixture consisting of Ebecryl 600 (44.8%), Uvecryl P36 (5.3%),  
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Figure 3.9;  A plot showing the potentiometric response of the Ca2+ MAMP sensor.  The sensor has a decidedly 
sub-Nernstian response of ~ 15 mV per decade of Ca2+ concentration. 
 
1,6-hexanedioldiacrylate (22.3%), potassium tetrakis(4-chlorophenyl)borate (0.6%), 
dioctylphenyl phosphonate (20.9%) and the ionophore CaTBPP (6.1%) using a fine brush.  The 
entire sensor head assembly was then irradiated with an ultraviolet lamp (140 W quartz halogen) 
under an argon blanket to preserve an inert atmosphere during polymerization, and the mixture 
was cured until hard and transparent (~ 5 minutes).  The resulting film was then washed with 
ethanol and DI water, and pre-conditioned in a 100 mM CaCl2 solution (pH 5.0) overnight prior 
to any measurements.   
Figure 3.9 shows a calibration curve for the Ca2+ sensor over the range from 0.1 to 3 mM 
Ca2+.  While the electrode response is linear (R2 = 0.9874) the response is decidedly sub-
Nernstian, yielding 17.2 mV of sensor response per decade (over 1.3 decades) instead of the 
theoretical 29.6 mV for a bivalent cation.  It is unclear why this is the case, as the original sensor 
was reported to have a hyper-Nernstian response of 32.3 mV/decade of concentration.83  
Anecdotally, the sensors were cured with a quartz-halogen UV source which generated excess 
amounts of heat, enough in fact to discolor the epoxy used to seal them into the sensor head, 
which could have damaged the film during polymerization.  Additionally, the sensors were only 
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utilized for one round of experiments, so variations in sensor response from batch to batch could 
not be observed. 
 
Results and Discussion 
Experimental Data 
In order to study the dynamic aspects of cellular metabolism in real time, as required for 
metabolomic studies, a technique should be able to track multiple key biomarkers in real time as a 
function of metabolic agent exposure to live cells.  The results of one such set of experiments for 
the exposure of PC12 cells to the OP agent parathion is shown in Fig. 3.10.  The experiment 
followed the cellular production of H+, lactate and dopamine, and for the uptake of glucose and 
Ca2+ as a function of time for a variety of concentrations of parathion ranging from 1 µM to  
 
Figure 3.10;  Relative changes in metabolic functions as a result of the exposure of PC12 cells to the OP toxin 
parathion.  The results for Ca2+ (blue triangles) and glucose (purple circles) uptake, as well as expression of 
dopamine (black diamonds), lactate (green circles) and H+ (red circles) were followed during exposure of the 
cells to levels of parathion ranging from 1 µM to 1 mM in a mixture of MAMP running media containing 2.5% 
DMSO.  The levels were normalized with respect to the levels observed prior to exposure to parathion, and data 
points were smoothed via adjacent averaging (n = 3) to facilitate the observation of any trends as a function of 
OP exposure. 
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1 mM.  The figure depicts the changes in metabolic activities, rather than the direct quantitative 
activity, which has been  normalized with respect to the initial levels prior to exposure, in order to 
evaluate the effect of the multiple cellular pathways to the different levels of toxin exposure.  The 
data points have also been smoothed, via adjacent averaging (n = 3) to better represent the trends 
of the changes in metabolic activity as a function of increasing parathion concentration.  The use 
of such a plot is to elucidate possible ties between different pathways that might not be obvious 
looking at the individual data sets.  For example, while the data for H+ production appears nearly 
flat throughout the experiment, three jumps are observable.  The first, at ~ 190 minutes, coincides 
with the beginning of a decrease in glucose uptake.  The next two, at around 230 and 260 minutes 
respectively, coincide with the initiations of a decrease in lactate metabolism.  While the cause of  
 
 
Figure 3.11;  changes in dopamine release from PC12 cells in response to exposure to the OP toxin parathion.  
Numbers given are production in attomoles (10-18 moles) per cell per second, with standard deviations.  
Parathion concentrations, listed on the graph, were 1 µM, 10 µM, 0.1 mM, 0.5 mM, and 1 mM.  Data was F-
tested and t-tested, and the differences in the mean and variance for all parathion exposures were found to be 
significant at the 95% confidence level with respect to both the initial RPMI and DMSO media as controls data 
(see Appendix B). 
 
 
49 
 
these events may not be readily discernable, or even definitively linked, they can suggest 
possibilities for further investigation or for inclusion in future in-silico analyses. 
While it is common to look at relative changes in metabolic activity for toxicity studies, 
the field of metabolomics focuses on quantitative, more than qualitative, analyses of metabolites.  
The same dopamine data, converted to production per cell per second, is presented in Fig. 3.11.  
The data shows that rather than a continual level of dopamine production at any given OP 
exposure, dopamine is actually released in bursts of variable intensity.  During the course of the 
experiment, average dopamine production ranged from 10 − 60 × 10-18 moles cell-1 second-1.  The 
dopamine production is initially stimulated by addition of DMSO to the media, and increasingly 
stimulated by addition of 1 µM and 10 µM parathion concentrations.  The average dopamine 
production remains constant through the 100 µM exposure, albeit with increase burst intensity, 
then both intensity and average output begins to decline upon exposure to 500 µM and 1 mM 
 
 
Figure 3.12;  fluctuations in net Ca2+ uptake by PC12 cells in response to exposure to the OP toxin parathion.  
Numbers given are uptake in attomoles (10-18 moles) per cell per second, with standard deviations. Parathion 
concentrations, listed on the graph, were 1 µM, 10 µM, 0.1 mM, 0.5 mM, and 1 mM.  Data was F-tested and t-
tested, and the differences in the mean and variance for only the 10 and 100 µm parathion exposures were found 
to be significant at the 95% confidence level with respect to the DMSO media data (see Appendix B). 
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parathion.  The removal of all parathion decreases the intensity of the fluctuations in dopamine 
production, and allows a partial recovery to the basal metabolic production rate. 
The quantitative net uptake of Ca2+ by the PC12 cells during the course of the experiment 
is shown in Fig. 3.12.  Variations in Ca2+ uptake were seen to range from ~ 1.5 to 6 × 10-18 moles 
cell-1 second-1.  Ca2+ uptake and release is known to occur in an oscillatory form in neurons, and 
uptake can be seen to modulate significantly after exposure to parathion.  A slight increase in net 
Ca2+ can be observed from the 1 µM to the 10 µM parathion exposure, and is maintained 
throughout the 100 µm exposure, but subsequent increases in parathion concentration do not 
seem to increase the maximum detected levels beyond that.  Statistically, according to F-test and 
t-test analysis, the 10 µM  and 100 µM exposures are the only two significantly different at the 
95% confidence level from the DMSO control data (see Appendix B).  This is probably due 
 
 
Figure 3.13;  changes in glucose uptake by PC12 cells in response to exposure to the OP toxin parathion. 
Numbers given are glucose uptake in attomoles (10-18 moles) per cell per second, with standard deviations.  
Parathion concentrations, listed on the graph, were 1 µM, 10 µM, 0.1 mM, 0.5 mM, and 1 mM.  Data was F-
tested and t-tested, and the differences in the mean and variance for all parathion exposures were found to be 
significant at the 95% confidence level with respect to both the initial RPMI and DMSO media as controls (see 
Appendix B). 
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to the low signal to noise ratio caused by attempting to measure small fluctuations in Ca2+ media 
concentration against a high bulk background concentration. 
Like Ca2+ uptake, the glucose uptake observed by the PC12 cells showed an oscillatory 
trend (Fig. 3.13).  Unlike the previous measurements, however, the glucose uptake was observed 
to reduce below the level of detection, shown in Fig. 3.13, at a several points during the 500 µM 
and 1 mM OP exposures.  The consequences of this would be a virtual shutdown of the entire 
glycolytic pathway.  Prior to parathion exposure, the average glucose uptake is observed to be 
75 – 80 × 10-18 moles cell-1second-1 for RPMI only, decreasing to ~ 60 × 10-18  moles cell-1 
second-1 after DMSO is mixed with the media.  Average glucose uptake after parathion exposure 
tends to decrease in proportion to increasing parathion concentration.  
 
 
Figure 3.14;  changes in lactate production by PC12 cells in response to exposure to the OP toxin parathion.  
Numbers given are production in attomoles (10-18 moles) per cell per second, with standard deviations.  
Parathion concentrations, listed on the graph, were 1 µM, 10 µM, 0.1 mM, 0.5 mM, and 1 mM.  Data was F-
tested and t-tested, and the differences in the mean and variance for all parathion exposures were found to be 
significant at the 95% confidence level with respect to both the initial RPMI and DMSO media as controls data 
(see Appendix B). 
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 The changes in lactate production of PC12 cells measured during the experiment are 
presented in Fig. 3.14.  An initial increase in lactate production, indicative of a shift toward 
anaerobic metabolism, is observed upon exposure to DMSO.  Lactate production continues to 
increase throughout the 1 µM parathion exposure, where production averages ~ 1 × 10-18  mole 
cell-1 second-1.  After this point production decreases gradually for the 10 µM and 100 µM 
exposures prior to dropping off steeply after being exposed to 500 µM parathion.  The same 
average production (~ 0.3 × 10-18  mole cell-1 second-1) is then observed until the parathion is 
removed.  After return to normal RPMI media, the average production drops further (to ~ 0.2 × 
10-18  mole cell-1 second-1) at which time an oscillatory production pattern initiates. 
 
Validation of Signaling and Metabolic Pathways 
a. Validation of Glycolysis Model 
Modeling of metabolic enzyme kinetics requires the consideration of enzymatic kinetic 
mechanisms such as Ordered Bi-Bi, Random Bi-Bi, Ping Pong Bi-Bi and Multi-site Ping Pong 
kinetics.  Enzyme kinetics are known to be highly regulated by competitive and non-competitive 
inhibition/activation.  In addition to metabolic enzyme kinetics, metabolite membrane transport 
mechanisms need to be accounted for because the predictions will ultimately be compared to 
microphysiometer experimental data.  During validation, model parameter values used in the 
glycolysis model were based on previously published experimental values,78 with equations and 
coefficients taken from that work.  Since all model equations are fully reversible, a 
thermodynamic analysis of the pathway can be performed.  The overall equilibrium expression 
for glycolysis is:  
3
3
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Running the dynamic model to steady state yields an overall equilibrium coefficient of 
1.559 × 1019 M-1. This translates to a free energy drop of -27.32 kcal mol-1, in excellent agreement 
with the published value.84  Each individual reaction was tested for equilibrium accuracy and 
compared to the published values84 with excellent agreement.  The model dependence on cellular 
ATP usage was tested in order to determine the redox and phosphorylation potential within the 
cytosol.  Figure 3.14 is a plot of the steady-state dependence of the model under increasing ATP 
usage loads.  Initially, the redox potential increases with increased carbon flux through the  
 
 
Figure 3.15;  Plot of the cytosolic redox and phosphorylation potential variation with ATP usage. 
 
glycolysis cycle.  The redox potential attains a maximum at an ATP usage of approximately 55 
mM/min.  Past this point, there is a sharp drop in the cytosolic ATP concentration due to a 
breakdown in the ATP buffering.  This causes an increase in ADP and free phosphate, indicated 
by a rapid decrease in the cytosolic phosphorylation state of the cell (Fig. 3.15).  Total carbon 
flux through the system increases linearly with ATP usage throughout the entire range (Fig. 3.16), 
indicating that the total carbon flux is relatively insensitive to the redox and phosphorylation 
potential within the cell, and primarily determined by ATP usage.  Enzymes responsible for 
NAD/NADH turnover (LDH and GAPDH) do not contribute heavily to the carbon flux control.85 
This explains the insensitivity of the total carbon flux to the cytosolic redox potential. 
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Figure 3.16;  Plot of the total carbon flux and cytosolic ATP level variation with ATP usage. 
 
 
Figure 3.17;  Dependence of the NADH (a) and ADP (b) components of the metabolic model to nutrient 
availability. 
 
b. Validation of Mitochondrial Model 
Steady state model response to substrate availability was examined by varying the 
AcCoA concentration.  Increasing the AcCoA concentration to a maximum of 5 mM causes a 
twofold increase in the respiration rate (VO2); beyond this point the VO2 saturates (Fig. 3.17a).  
The increase in VO2 is driven by the generation of NADH in the range of 0.01–1.6 mM (Fig. 
3.17a).  The increasing respiration rate also causes an increase in the usage of ADP, decreasing 
the mitochondrial concentration from 3.2 to 1.75 mM (Fig. 3.17b).  The VO2 at low AcCoA 
concentration is driven primarily by consumption of glutamate (see Fig. 3.5).  Stimulation of 
electron transport is associated with a 6 mV increase (Fig. 3.18) in membrane potential (∆Ψm).  
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The linear relationship between VO2 and ∆Ψm (Fig. 3.18) is in agreement with experimental 
results.79 
Mitochondrial function is altered by Ca2+ in two opposing ways.   First, the influx of Ca2+ 
causes a decrease in the ∆Ψm, decreasing the proton motive force.   Second, the presence of Ca2+ 
in the mitochondria stimulates the production of NADH, increasing the proton motive force.  The 
 
 
Figure 3.18;  Dependence of the mitochondrial respiration rate on membrane potential. 
 
steady state response of the model to changes in cytosolic Ca2+ concentration in the physiological 
range (0.01 to 2.0 µM) is shown in Figure 3.18.  Mitochondrial Ca2+ exponentially increases once 
the cytosolic Ca2+ concentration increases to above 0.50 µM.  The mitochondrial Ca2+ 
concentration continues to increase to 30 µM without saturation (Fig. 3.19a).  The threshold value 
for cytosolic Ca2+ is set by the relative rates of the Ca2+ uniporter and the Na+/Ca2+ antiporter, 
which are coupled indirectly through ∆Ψm. The resultant mitochondrial Ca2+ profile compares 
well with experimental results.79 
An increase in the VO2 with increasing mitochondrial Ca2+ is evident in Figure 3.19a.  
Along with the increasing VO2, the steady-state flux through the Ca2+- sensitive dehydrogenases 
also increases with increased mitochondrial Ca2+ (isocitrate dehydrogenase (IDH) shown in 
Fig. 3.19a). The dependence of ∆Ψm on mitochondrial Ca2+ illustrates the opposing action of Ca2+ 
transport. Below a cytosolic Ca2+ concentration of 0.40 µM, the membrane potential increases to 
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a maximum value of 125 mV.  An increase in the cytosolic Ca2+ concentration beyond this point 
causes a large influx of Ca2+, decreasing the ∆Ψm by depolarizing the inner membrane. 
At low cytosolic Ca2+ concentration, the increase in dehydrogenase activity increases the 
concentration of NADH within the mitochondria.  The decrease in NADH at higher cytosolic 
Ca2+ concentration is caused by the saturation of the stimulatory effect on dehydrogenase activity 
 
 
Figure 3.19;  Dependence of the mitochondrial model on cytosolic Ca2+ concentrations. 
 
concomitant with an increase in respiration rate (Fig. 3.19b).  The dependence of ADP on 
cytosolic Ca2+ is the result of the interplay of the NADH and respiration.  The dip in ADP 
concentration is driven by the increased availability of NADH, while the increase in ADP 
concentration results from a rapid decline in the NADH levels.  The ADP increase does not 
directly track with the NADH decrease because ADP is consumed during respiration. 
c. Intracellular Signaling and Calcium Dynamics Model Performance 
In contrast to the metabolic pathways, signaling pathway mechanisms can be modeled 
primarily by mass-action kinetics.  Initial species association/dissociation interactions are 
required to induce downstream protein phosphorylation/dephosphorylation through various 
protein kinase and phosphatase reactions.  Metabolic and signaling pathways are linked via 
second messengers (i.e. calcium, cAMP), the availability of high-energy phosphate pools, and the 
redox state of the cell.  General biochemical reactions included in this cellular signal transduction 
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network include ligand-protein interactions, protein-protein interactions, protein phosphorylation 
and dephosphorylation, enzymatic activity and trafficking of second messengers, such as calcium, 
cAMP, and IP3.  All kinetic coefficients used in the signaling and calcium dynamics model were 
taken from previously published experimental and theoretical studies.80,81 
 
 
Figure 3.20;  Plot of MAPK activity with variation in ACh concentration. 
 
A set of example calculations were performed in order to demonstrate the signaling 
pathway.  The cell is assumed to be in homeostasis at time zero, at which time the cell is exposed 
to acetylcholine.  The acetylcholine buildup is assumed to be caused by the inhibition of the 
acetylcholinesterase by an OP compound.  The activation of mitogen activated protein kinases 
(MAPKs), PLCγ, and intracellular Ca2+ was plotted in order to demonstrate the dose response 
behavior of the model.  Figure 3.20 illustrates the dose-dependent activation of MAPK at the two 
concentrations of acetylcholine (10 and 100 nM).  The sharp increase in MAPK activity is 
attributed to rapid extracellular influx of calcium into the cytoplasm and concomitant release of 
calcium from the endoplasmic pools.  The relatively slower phosphatase action then reduces the 
overall activity, however, even at a small dose there is persistent activation of 10% MAPK.  At a 
higher dose, the time scale for activation is much faster, with a peak activation of close to 100%, 
and approximately 50% remaining active with persistent acetylcholine stimulation.  
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Figure 3.21;  Plot of PLCγ activity against cytosolic calcium concentration with variation in ACh concentration. 
 
Figure 3.21 is a plot of the dependence of PLCγ activity on cytosolic calcium.  This plot 
indicates that there is a concentration range where the PLCγ activity increases linearly with 
calcium concentration.  However, as the cytosolic calcium concentration increases to 
approximately 2 µM, the activity increases rapidly for the high dose curve and shows only 
modest increase with the low dose curve.  The rapid increase in activity is due to a positive 
feedback loop between the secondary messenger IP3 and calcium release, which is catalyzed by 
PLCγ. 
d. Validating Dopamine Release Model 
A model of dopamine release was constructed using the existing signaling pathway 
models, and was fitted to the data.  The model accounts for the buildup of acetylcholine in the 
extracellular space due to the inhibition of the acetylcholinesterase (AChE) by parathion.  The 
excess acetylcholine binds to the acetylcholine receptor (AChR) and activates the PLCγ−Ca2+ 
complex leading to the formation of IP3.  The excess IP3 causes the release of Ca2+ from the 
endoplasmic reticulum causing an increase in the cytosolic calcium, ultimately catalyzing the 
release of dopamine (Fig. 3.22). 
We used the existing virtual MAMP simulation environment to fully couple the 
pump/stop action of the MAMP and its sensors to the predictive, dynamic model of dopamine  
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Figure 3.22;  (a) OP compounds bind to AChE, causing an increase in acetylcholine (ACh).  The excess ACh 
binds to the ACh receptor activating the PLCγ pathway. (b) The bound AChR complex triggers the formation of 
IP3 catalyzed by the PLCγ−Ca2+ complex. (c) IP3 triggers the release of Ca2+ from the endoplasmic reticulum, 
increasing the cytosolic calcium concentration, leading to the release of dopamine. 
 
release.  Simulations were performed using the coupled system with an MAMP pump time of 80 
sec and a stop time of 40 sec.  The parathion scheduling and cytosolic calcium response is given 
in Fig. 3.23.  Cytosolic calcium rises rapidly with increasing parathion concentration (Fig. 3.24), 
due to the positive feedback loop formed between PLCγ and cytosolic Ca2+ (see Fig. 3.21).  The 
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Figure 3.23;  Correlation between cytosolic Ca2+ concentration and parathion exposure. 
 
 
 
Figure 3.24;  Parathion scheduling and the cytosolic calcium response. 
 
response of the measured and simulated dopamine release by the system in response to the 
parathion scheduling shown in Figure 3.25.  The model predicts the basal release of dopamine 
quite well.  As with the data, the model predicts an increased dopamine release with increasing 
parathion concentration, up to a parathion concentration of 100 µM.  At this point the model 
predicts a decrease in the overall release of dopamine.  The model also captures the some of the 
“spiking” of dopamine release during transitions from one parathion concentration to another.  
The spikes are due to an abrupt increase in the release rate upon changing cytosolic Ca2+ 
concentrations, temporarily depleting the internal dopamine stores.  Once the release rate gets 
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Figure 3.25;  Comparison of the experimentally measured dopamine release to the release projected by the 
assembled model system. 
 
high enough, the rate of production of dopamine is insufficient to replenish internal stores, and 
the amount of dopamine released decreases.  Therefore, the model is capable of capturing the 
salient features of the dependence of dopamine release in PC12 cells upon external parathion 
concentration.  
 
Conclusions 
Two new sensors, for dopamine and Ca2+, were incorporated into the MAMP platform 
and used for the first time.  While the dopamine sensor successfully recorded production, due to 
less than favorable signal-to-noise ratios, the Ca2+ sensor was less reliable.  With the exception of 
the previously mentioned Ca2+ data, the mean and variance for all data collected for each 
parathion exposure was found to be statistically significant at the 05% confidence level (full F-
test and t-test results are in Appendix B).   
The model neuronal cell line PC12 was utilized to examine the effects of exposure of the 
OP compound parathion at a variety of concentrations ranging from 1 µM to 1 mM.  Quantitative 
as well as qualitative data were presented for the OP mediated changes in the metabolic cellular 
uptake of glucose and Ca2+, as well as for changes in the production of lactate, and dopamine.  
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Qualitative data was also presented for the changes in extracellular acidification during parathion 
exposure.   
A complete cell signaling pathway model was assembled in-silico by researchers at CFD 
Research corporation using data collected in our labs during prior MAMP experiments.  This 
model was then applied to the data presented here in order to evaluate its ability to predict 
dopamine production by PC12 cells due to parathion exposure.  The comparison of the dopamine 
model predictions to the experimental data collected shows agreement for the overall trends in 
dopamine production as a function of exposure to  parathion. 
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CHAPTER IV 
 
METABOLIC PROFILING OF PANCREATIC ISLETS VIA MAMP AND SECM 
 
Introduction 
Diabetes Mellitus is a disease that currently affects approximately 246 million people 
worldwide,1 resulting in impairment of physiological glucose metabolism.  Diabetes is currently 
the fourth leading cause of death by disease world-wide, with one person every 10 seconds dying 
from a diabetes-related cause.1 Normal glucose homeostasis is regulated in the pancreas by the 
islets of Langerhans through a feedback loop involving production of the hormones insulin and 
glucagon.  There are three recognized subtypes of diabetes; type I diabetes, also known as early-
onset diabetes, is generally thought to result from autoimmune destruction of insulin producing β-
cells within the islets themselves, type II diabetes is caused by insulin resistance in muscle and 
liver tissue, which prevents uptake and storage of glucose in the body, and gestational diabetes, 
the final type, which only occurs during pregnancy.  Regardless of the cause, chronic elevated 
glucose levels inevitably lead to abnormally high levels of reactive oxygen species in the blood, 
which in turn cause the symptomatic damage to the eyes, kidneys, nerves, and blood vessels.2   
Pancreatic islets are true micro organs, consisting of four different cell types; α-cells 
which produce glucagon, β-cells which produce the hormone insulin, δ-cells which produce 
somatostatin, and pancreatic polypeptide producing PP-cells.3  Glucose homeostasis is maintained  
specifically through the activities of α-cells, which produce glucagon in the event of 
hyperglycemia (low glucose), β-cells which produce insulin in the event of hypoglycemia (high 
glucose), and δ-cells whose role is the paracrine modulation of their neighboring α- and β-cells.4  
Therefore it is the antagonist action of both insulin and glucagon that ensures glycemia within the 
physiologically normative range.  
67 
 
While a majority of research focuses on murine (mouse or rat) islets, there are differences 
between murine and human islets.  Murine islets, for example, tend to have higher concentrations 
of β-cells (85% vs. 54 % for human islets) and they are all located at the islet core (vs. a random 
cross-sectional distribution for human islets).5,6  Insulin secretion can be triggered by glucose, K+, 
amino acids, and a variety of other molecules.7-10  Glucose stimulated insulin release has been 
shown to be biphasic in nature, with an initial short burst followed by a longer, sustained 
release.11  The shorter bursts are thought to come from a β-cell ‘ready release pool’ while the 
sustained bursts come from a ‘reserve pool.’  The release of insulin from islet β-cells is known to 
be pulsatile in nature due to a cascading chain of events beginning with  oscillations in membrane 
potential, which cause oscillations in Ca2+, which in turn drive oscillations in insulin production.12  
The pulsatile nature of insulin release results in oscillations in blood concentrations in-vivo with 
two predominant periods, one high frequency (6 – 10 minutes) and the other low frequency (140 
minutes), which is also called the ultradian periodicity.13,14 
The first generation of islet viability assays were typically derived from general cell 
culture techniques (i.e., dye based techniques),15 and did not focus on insulin production capacity 
of pancreatic β-cells.  This posed a problem because the islet as a whole has been shown to 
continue living after its β-cells have died.16  Currently utilized non-electrochemical assays require 
either static immersion or perfusion while exposed to both low (2.8 – 3.3 mM) and high (16.7 – 
20 mM) physiological glucose levels. The insulin secreted is then detected via ex-situ analysis 
utilizing radioimmunoassay,17 chemiluminescence,18 fluorescence microscopy,19 or ELISA.20  
Initial publications for electrochemical methods to assay insulin secretion itself utilized 
indirect methods of detection.  In 1996, Barbosa21  and co-workers discovered that the 
electroactive amine 5-HT, upon entering an islet, concentrates within insulin granules.  Upon 
stimulation, the 5-HT is secreted along with insulin, and can be detected at a glass shielded 
carbon-fiber microelectrode.  Without knowing the ratio of insulin to 5-HT within the granules, 
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however, quantitative estimations of insulin secretion are not possible.  Later researchers have 
utilized chip-based capillary electrophoresis,22 which is able to quantify insulin secretion with 
detection limits as low as 0.8 nM and at a 6 second sampling frequency, but which also requires 
the addition of fluorescein isothiocyanate-labeled insulin and a monoclonal anti-insulin antibody 
for detection.   Anodic stripping voltammetry at a bismuth-coated glassy GCE23 is also employed 
to indirectly detect insulin via its zinc co-factor.  Finally, insulin exocytosis from isolated 
pancreatic β-cells can also be detected by changes in membrane capacitance,24 but this method is 
not quantitative.  
Direct electrochemical detection of insulin would be preferable, as it requires no added 
agents for detection, and would provide a real-time measure of insulin secretion, which would of 
course be the preferred assay of islet viability.  One potential problem with direct electrochemical 
detection, however, could be the possibility of interference by somatostatin which is produced by 
islet δ-cells and has an oxidation potential close to that of insulin itself (+ 0.80 V for 
somatostatin, vs. + 0.88 V for insulin).25  Early attempts at direct electrochemical insulin 
detection centered on ruthenium or iridium based systems.  These included ruthenium 
dioxide/cyanoruthenate sensors,26,27  ruthenium oxide films on carbon-fiber electrodes,28 
ruthenium metallo-dendrimers,29  or iridium oxide films on glassy carbon.30  The ruthenium 
oxide/dendrimer systems, however, have mixed redox states which result in complex electron 
transfer kinetics.31 Likewise, the iridium oxide systems suffer from reduced kinetics due to the 
slower nature of proton transport, resulting in a slower electrode response and, more importantly, 
pH sensitivity. 32   
Recent years have seen the move toward biosensors based on carbon nanotubes, because 
of reduced susceptibility to biofouling33 and increased electrocatalytic properties.34  More 
recently, studies have shown specific propensity to catalyze electron transfer at biomolecules35,36 
as well as at embedded protein redox centers.37,38  Wang and Musameh were the first to show 
insulin detection at a GCE modified with a multiwalled carbon nanotube/N,N-
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dimethylformamide (MWCNT/DMF) film.39  More recent efforts by Wang’s group include a 
nanotube modified ruthenium oxide electrode, which further reduces biofouling tendencies, but 
adds the same pH sensitivity and mixed oxidation states of previous oxide films.40  A 
chitosan/MWCNT composite electrode has also been demonstrated for insulin oxidation,41 but the 
technique resulted in film thicknesses of ~ 10 µm, which is not feasible for use with UME 
sensors.  An alternative MWCNT composite insulin sensor featuring DHP42 has been previously 
developed in our labs during development of the multianalyte microphysiometer.42-46  DHP is a 
relatively small vinyl ether (Fig. 4.1) that has been shown to self-polymerize, which allows for 
thinner adherent MWCNT films to be cast onto UME sensors.  Furthermore, the MWCNT/DHP 
sensor was found to have a higher sensitivity, and a higher film cohesion, than the 
MWCNT/DMF sensors.47 
 
 
Figure 4.1; 3,4-dihydro-2H-pyran (DHP) is known to self polymerize, providing cohesion to the MWCNT film. 
 
Recent studies in our lab have utilized the MAMP to study the metabolic activity of a 
wide variety of cell types, and with the addition of the MWCNT/DHP sensor we can now apply 
the MAMP toward pancreatic islet studies as well.  Since it has been shown that lactate 
dehydrogenase (LDH) in islet β-cells is roughly 1/8 of that in other islet cell types, β-cells are 
thought to produce little, if any, lactate.48  This fact gives us the opportunity to perform 
simultaneous measurements that target both β-cell metabolism (through insulin) and α-, δ-, and 
PP-cell metabolism (through lactate).   
 Experiments performed in the MAMP, however, track an averaged change in 
metabolism across a large number of islets (typically 75 – 100).  While this allows us to follow 
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the overall response of the islet population, it does not permit the study of individual islets.  In 
order to observe the activities of a single islet, which could lead to a better understanding of intra-
islet metabolism and signaling, a more sensitive technique, and one more appropriate to the 
spatial scale of a single pancreatic islet, must be applied. 
SECM has proven a valuable tool in the investigations of a variety of biological 
phenomena,49-52 especially due to its ability to generate spatio-temporal maps of metabolic flux 
across a cell surface.  Recent adaptations in the instrumentation of SECM have allowed easier 
inclusion of biological samples in experiments.  These instruments are termed biological scanning 
electrochemical microscopes (Bio-SECM),53 and typically feature the inclusion of an inverted 
microscope (for both assistance in positioning electrodes and imaging the subject) as well as other 
elements critical for maintaining a viable biological environment (stage heaters, perfusion, etc.).    
The inception of SECM single cell investigations has led to a number of studies focusing 
on a variety of cell types, and extensive reviews are available elsewhere.54,55  The difference in 
redox activities between metastatic and non-metastatic human breast cancer cells have been 
studied extensively.56-60 These studies have also identified a class of redox mediators that are 
capable of penetrating the cell membrane, and investigated their distribution between the cytosol 
and nucleus.  Several works have been published as well on the neuronal analog PC12 cell line, 
including imaging of topography and mitochondrial respiration61-63 (also see Chapter 5), real-time 
changes in morphology,64 as well as catecholamine release.65  Recent work with other cell lines 
has included the imaging of NO release from T-HUVEC cells,66 HeLa cell activity through the 
use of a ferrocene derivative,67 and conversion of menadione to thiodione in single 
hepablastomas.68 Work in our labs has also added the capability of using enzyme-coated UMEs to 
study the metabolic profiles of both glucose and lactate in cultured fibroblasts (see chapter 5), and 
to image analogs of ion channel systems in reconstituted lipid bilayer membranes (see chapter 6).   
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Experimental 
Materials 
All materials were used without modification unless otherwise noted.  Insulin (from 
bovine pancreas, 27 USP units/mg) was purchased from Sigma. 3,4-Dihydro-2H-pyran (DHP), 
and Tween-80 were purchased from Acros, and KCl from Fisher. Cell-TakTM cell and tissue 
adhesive was purchased from BD Biosciences.  Glassy carbon rods (1 mm diameter) were 
obtained from Structure Probe, Inc. (West Chester, PA).  Platinum rod (2 mm) was purchased 
from VWR.  All microphysiometer consumables were purchased from Molecular Devices 
(Sunnyvale, CA).  Insulin solutions were prepared from a stock of 10 mg/mL solution of insulin 
in 19.6 mM hydrochloric acid containing 0.02% v/v Tween-80.  Dilutions were then made in 50 
mM phosphate buffer (pH 7.4, 0.02% v/v Tween-80) immediately before use in experiments.  
MWCNTs were obtained as a gift from Dr. William Hofmeister and were manufactured as a 
byproduct of diamond deposition by microwave assisted chemical vapor deposition using an iron 
catalyst. An Astex Large Area Diamond Deposition System with a 5 kW microwave source was 
used. Nanotubes were purified through treatment with nitric acid, following the method of 
Dujardin et al.,69 to remove the remaining catalyst and aggregates. Following purification, the 
nanotubes were dried in an oven (1300U, VWR Scientific) and stored in a desiccator.   
ASTM Type I (18 MΩ) analytical grade deionized water (DI) was obtained with a 
Solution 2000 Water Purification System from Solution Consultants.  All solutions used in UME 
analyses or for SECM imaging were filtered prior to use with 0.2 µm syringe filters from Fisher.  
Ferrocenylmethyltrimethylammonium hexafluorophosphate (FcTMA) was prepared according to 
the method of Mirkin and co-workers.70 
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Figure 4.2;  Islets were visually inspected prior to selection for experiments in the MAMP and the SECM.  
Healthy islets (a) were intact and translucent with a white to golden color, while unhealthy islets (b) had dark 
coloration (due to necrosis) and were observed to shed dying cells. 
 
Islets 
Male Friend leukemia virus B (FVB) mice were made available by the Islet Isolation 
Core of the Vanderbilt Diabetes Research and Training Center, where islets were isolated from 
these mice by Dr. Zhongyi Chen as described by Brissova et al.71  FVB mice have been used 
previously as control models for basal levels in a number of studies of the effect of gene 
modification on insulin secretion.72-74    The islets were cultured overnight in RPMI with 10% 
fetal bovine serum and 11 mM glucose. Upon receipt the islets were stored in an incubator at 37 
°C and 5% CO2 and typically used within 24 hours.   Optical microscopy was used to 
qualitatively judge viability when choosing islets for both culturing and imaging.  A transparent 
to golden color was indicative of a healthy subject (see fig. 4.2a), while the presence of necrotic 
(darkened) spots, or the visible shedding of cells, was indicative of a non-viable islet (see fig 
4.2b).   
In preparation for islet MAMP experiments, Cytosensor® capsule cups were coated with 
the tissue adhesive Cell-TakTM, then were dried at 37 °C, rinsed, then dried again.  Islets, 
numbering 75 – 100, were handpicked from the culture media using a manual pipette, then rinsed 
3x in 1 mM phosphate buffer supplemented with 100 mM NaCl and then placed onto the capsule 
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cup membrane.  The islets were then coated with 5 µL of agarose, following the Molecular 
Devices suggestion for non-adherent cells in the Cytosensor Microphysiometer® (Fig. 4.3).69   
 
 
Figure 4.3;  A schematic of the agarose entrapment of islets in the MAMP.  The islets (in gold) are at the bottom 
of the capsule cup (light blue) and covered with 5 µl of agarose (green).   
 
Prior to SECM experiments, the islets were individually washed by a series of manual 
extractions, each taking the minimum possible volume of liquid, under a stereo microscope via a 
manual micropipette into a much larger volume of fresh media (Hanks Buffered Salt Solution, 
HBSS) in a new, sterile culture dish.  35 mm glass bottom culture dishes (WillCo dishes), used 
for imaging, were initially coated with 10 µl Cell-Tak (BD Biosciences) to promote adhesion, 
then dried in an oven (1300U, VWR Scientific) at 37 °C for two hours, rinsed with several 
washings of sterile DI water (~100 µl each), then returned to the oven for a second drying.  The 
islets were then transferred (also using the minimum possible volume) onto the coated surface of 
the culture dish, and covered with HBSS supplemented with 5 mM glucose. In preparation for 
imaging, dishes were removed from the incubator and placed in the stage warmer, and fresh 
media applied.  The islets were allowed to rest at least 30 minutes, in order for the entire system 
to equilibrate and reach proper physiological temperature prior to imaging.   
 
Instrumentation 
a. CH Instrument 660A potentiostat 
Electrochemical measurements for calibration and sensitivity testing were performed 
using a model 660A potentiostat (CH Instruments, Austin, TX), in the included Faraday cage 
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with picoamp current booster, and using a standard 3-electrode electrochemical setup.  
Experiments utilized MAMP sensor heads and UMEs as WE, commercial macro Ag/AgCl REs 
(CH Instruments model CHI111), and Pt mesh or coiled Pt wire CEs fabricated in our lab.  Prior 
to use in experiments, insulin sensors (both for MAMP and SECM) were tested for sensitivity 
using constant potential amperometry with standard additions of insulin to 50 mM phosphate 
buffer (pH 7.4, 0.02 % v/v Tween-80).  LSV was accomplished using a scan rate of 50 mV·s-1, 
while the bias used for constant potential amperometry was + 0.88 V vs. Ag/AgCl, 2M KCl RE. 
b.  MAMP 
Islet experiments performed in the MAMP utilized a sensor head with an integrated 1 mm 
GCE in the place of the 0.5 mm Pt glucose sensor (see chapter 3 section B1).  Electrical 
connection to the GCE was provided via silver epoxy to a Pt wire, and the assembly was sealed 
with Hysol® epoxy.  The MWCNT solution was prepared in DI water (10.5 mg·ml-1), and the 
MWCNTs were dispersed by sonication.  After 15 minutes 10 mg DHP was added while the 
suspension remained in the sonicator, and sonication was continued for another 15 minutes to mix 
thoroughly.  MAMP insulin sensors were fabricated by drop-casting 3 µL of the MWCNT/DHP 
solution onto the electrode surface.   
Due to hardware limitations, the glucose and lactate sensors in MAMP are forced to share 
the same potentiostat channel.  This is typically not a problem, since they require the same 
potential bias.  However, for islet experiments the glucose sensor in the MAMP was replaced 
with a MWCNT/DHP insulin sensor, requiring the potential bias of both to be set to + 0.88 V  in 
order to enable insulin detection during the experiments.  The lactate sensor was prepared as 
previously described (see chapter 3 section B1).  All potentials reported for MAMP experiments 
are vs. Ag/AgCl, 2 M KCl. 
Experiments in the MAMP that utilized a flow/stop-flow cycle were performed with 40 
seconds of quiescent stop-flow, when measurements are performed, followed by 140 seconds of 
media flow (20 µl·min-1) to replenish nutrients and remove waste from the cell chamber.  
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Continuous flow measurements were made using a slower flow rate of 4 µl·min-1.  The media 
used all for islet experiments was HBSS (‘running media’), supplemented with glucose at either 
2.8 mM (hereafter low glucose) or 16.7 mM (hereafter high glucose).  In flow/stop-flow 
experiments, islets were initially perfused with low glucose HBSS for 40 minutes, followed by 
high glucose HBSS for 40 minutes, and finally returning to low glucose HBSS for 30 minutes.  
Flow/stop-flow experiments performed to determine effects of K+ stimulation were done with the 
following sequence: low glucose (45 min.), high glucose (45 min.), low glucose (30 min.), high 
glucose (45 min.), low glucose (30 min.), low glucose + 50 mM KCl (48 minutes), then returning 
to low glucose.  Identical control experiments were conducted in the absence of islets to 
determine the effect of variable glucose levels on the sensor response.  
 
 
Figure 4.4;  Schematic of the Bio-SECM setup incorporating an arm extension to hold the UME, inverted 
microscope with digital camera, and a fiberoptic light for additional illumination. 
 
c.  SECM 
Experiments were performed using a Bio-SECM setup incorporating an inverted 
microscope (VistaVision, VWR) with digital camera (Pixera professional from Pixera Corp.), 
microscope stage temperature control with objective heater (TCII micro temperature controller, 
BioScience Tools) and a CH Instruments model 900 SECM (fig. 4.4) operating in the constant 
height mode. The use of an arm extension to hold the ultramicroelectrode (UME) allowed the 
positioning of the piezo micropositioners beside, rather than atop, the microscope platform. This 
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placement allows the microscope stage to move independently of the SECM tip so that cells/islets 
may be quickly positioned near the UME for imaging. The microscope stage and heater have 
been modified to adjust for substrate tilt (Fig. 4.5) by fabricating a stage insert that permits the 
heating stage to reside below the plane of the microscope stage.  This prevents z-axis adjustments 
to level the substrate from moving the dish out of the short working distance of the microscope 
objectives.  The heating stage ‘floats’ below the stage insert and is held in place against the 
leveling screws by high strength rubber tubing, which wraps around the top of the stage insert to 
secure the heating stage.  Since the microscope stage heater was designed for perfusion-type 
experiments, the internal thermocouple was removed from the perfusion tubing track, sterilized in 
EtOH, and placed directly into the cell culture dish during experiments to ensure proper 
temperature control.  All reported potentials for SECM experiments are measured versus a 
Ag/AgCl, 3 M KCl RE. 
 
 
Figure 4.5;  The modified stage insert for the inverted microscope top view (left) and a cutout cross section 
(right).  The circular metal heating stage is supported from below by high-strength rubber tubing (orange, 
shown at left but omitted at right), and substrate tilt is adjusted via the three leveling screws.  The heating stage 
thermocouple (in green) is immersed in the media inside the 35 mm glass-bottom dish to ensure proper 
temperature is maintained. 
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All UMEs utilized in these studies were of the disc-sealed-in-glass type, and had RG 
ratios50 of ~ 5.  Pt 25 µm and 10 µm electrodes were manufactured from Pt wire (Goodfellow), 
according to the method of Bard,50 polished using sizes of alumina (Buehler) down to 0.05 µm on 
a polishing wheel (Metaserv 2000, Buehler), then sonicated in EtOH and DI water.  UMEs were 
then electrochemically polished by cycling their potential in a solution of 0.5 M H2SO4.  The 
electrodes were then tested by performing cyclic voltammetry (CV) in a solution of 1 mM 
FcTMA (E = + 0.65 V).  Only Pt UMEs capable of reaching an increase in current of 800% (over 
initial steady state current values) during approach to a 2 mm Pt disc (e.g., those with IT = 8) were 
used for imaging purposes.  Carbon fiber UMEs (cf-UMEs) were manufactured similar to Pt 
UMEs except using 7 µm carbon fibers gifted by Dr. Aurelio Galli (Vanderbilt University). 
The insulin UME sensor was prepared using a 7 µm cf-UME by a slight modification of 
the MAMP procedure (see previous section).  Casting of the MWCNT film was accomplished by 
dispensing a single droplet of the solution manually from an Eppendorf tip, and waiting for the 
MWCNTs to aggregate at the bottom of the droplet.  The UME tip was then brought into contact 
with the mass of MWCNTs in the droplet and held there for 2 seconds, then withdrawn and held 
inverted (i.e., tip down) until the film dried.  The UME sensor was then carefully washed by 
repeatedly dipping into a vial of DI water and was stored in pH 7.0 phosphate buffer until use. 
Probe scan curves (PSCs) and imaging of oxygen respiration were performed using 
Nafion coated 25 µm or 10 µm Pt UMEs (Etip = − 0.5 V), in HBSS supplemented with 5 mM 
glucose.  The Nafion coating was hand cast by dipping the UMEs in a 5% solution of Nafion in 
EtOH (Strem), followed by drying with the UMEs in an inverted position, and rinsing repeatedly 
with DI water.  Topographical images were performed via the addition of 1 mM FcTMA to the 
HBSS islet media, with an uncoated 10 µm Pt UME (Etip = + 0.65 V). 
PSCs of insulin were obtained with the use of 7 µm carbon fiber UMEs coated with 
MWCNT/dihydropyran (Etip = + 0.88V) as previously discussed.  Prior to use in imaging 
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experiments, the UME insulin sensors were calibrated and tested for sensitivity via constant 
potential amperometry.  A stock solution of 1.4 mM bovine insulin was prepared in 0.02% 
TWEEN detergent (acidified to pH 2.0).  This solution was used to spike a pH 7.0 phosphate 
buffer solution to create total insulin concentrations of 200 nM, 500 nM, and 1 µM.    After 
sensitivity testing, the UMEs were carefully rinsed by dipping into DI water and stored in pH 7.0 
phosphate buffer until use.  Insulin release was triggered by spiking the media surrounding the 
islet with sufficient glucose from a stock solution via a micropipette to allow the concentration 
within the dish to reach 16.7 mM. 
 
Figure 4.6;  Calibration plots for (a) the macro-scale MAMP sensor and (b) the UME SECM insulin sensor.  The 
sensitivities for the electrodes were 1 µM for the MAMP sensor and 200 nM for the UME sensor. 
 
Sensor Calibration 
Calibration plots for both an MAMP sensor and a UME insulin sensor are shown in 
Fig. 4.6.  Both sensors show a linear response; with the MAMP the range is from 1 − 10 µM 
(Fig. 4.6a, R2 = 0.996) while for the UME sensor the linear range is from 0.2 – 1.0 µM (Fig. 4.6b, 
R2 = 0.9998).  The calibration for the MAMP sensor utilizes an average of five stop-flow cycles 
(n = 5).  The UME sensor provides nearly one decade higher insulin sensitivity (200 nM for the 
UME sensor vs. 1 µM for the MAMP sensor), and due to the reduced capacitance and 
background noise, a highly linear response that intercepts at the origin for zero insulin 
concentration. 
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Results & Discussion 
MAMP Islet Experiments 
a. Flow/stop flow experiments 
The insulin response of a MAMP insulin sensor head during one flow/stop-flow cycle to 
the physiological release from a group of ~ 100 islets is shown in Fig. 4.7.  The figure shows the 
current change due to the depletion of insulin in the solution immediately surrounding the sensor 
 
 
Figure 4.7;  The response of an MAMP insulin sensor to the insulin produced by a number of pancreatic islets 
(~100) during a single stop-flow cycle.  The peak current (ip) is taken as the change from the baseline during the 
stop-flow period.  The current is seen to decrease, instead of increase, due to diffusional limitations. 
 
when the solution flow stops, causing the observed drop in current.  The figure also depicts how 
measurements are made by subtracting the peak current from the baseline to get the peak height 
(ip), which is proportional to the insulin present in the media.  The raw data from a series of 
measurements performed using the MAMP insulin sensor in the presence of pancreatic islets (75 
– 100), at physiological low and high glucose levels (2.7 mM and 16.8 mM respectively), is 
shown in Fig. 4.8.  The overall sensor response, both baseline and peak size, can be seen to 
increase from low to high glucose levels, indicating an elevation of insulin exocytosis.  In order to 
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Figure 4.8;  Raw MAMP insulin data for an experiment exposing islets (75 – 100) to low physiological glucose 
levels (2.8 mM) and high physiological glucose levels (16.7 mM). 
 
evaluate the qualitative effect of changing the glucose level, we can assign the output at low 
glucose levels a normative state, and measure the percent change in activity as a result of 
increasing to high glucose levels.   
 
 
Figure 4.9;  The responses of MAMP sensors for (a) insulin and (b) lactate. For the insulin sensor (a), results are 
shown for low and high glucose both in the absence of (squares) and presence of (triangles) ~ 100 islets, at low 
(2.8 mM) and high (16.7 mM) physiological glucose levels.  (b) shows lactate production in the presence of islets 
at both low and high physiological glucose levels. 
 
In Fig 4.9 the result of such an evaluation is presented for insulin (4.9a) and lactate (4.9b) 
production.  The plot for insulin sensor response includes data collected both in the absence of 
(squares) and the presence of (triangles) islets.  The data collected in the absence of islets, both at 
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low glucose (squares with white background) and high glucose (solid black squares) show 
virtually no significant effect of changing glucose concentration on the sensor in the absence of 
insulin production.  The changes between low (pink triangles with white background) and high 
glucose levels (solid pink triangles) when islets are present, however, shows an increase of nearly 
125% in the insulin signal as a result of increasing the glucose levels.  This corresponds to more 
than double the output of insulin over the basal metabolic rate.  When observing the lactate 
production for the same islets we see an approximately 15% increase in lactate production for 
high glucose (green diamonds) vs. that during low glucose (green diamonds with white 
background).  Therefore when we see increases in both lactate and insulin production we are 
likely seeing simultaneous increases in metabolic rates of multiple cell types within the islet, 
further demonstrating the role of the islet as a true micro organ.  
Since K+ is also known to stimulate the release of insulin,75 an experiment was performed 
to see if that could be observed in the MAMP, and if so to compare K+ stimulated release to that 
of glucose.   The result from three MAMP channels for the experiment is shown in Fig. 4.10.  
Instead of relative changes in insulin output, however, the response has been quantitatively 
calculated from the sensor’s calibration response (see Fig. 4.6a) to show the insulin concentration 
(in µM) in the MAMP chamber.  The figure shows low glucose (pink triangles with white 
background) and high glucose (solid pink triangles) as in the previous figures, followed by 
stimulation with 50 mM K+ (solid purple triangles).  As before, we see differing  degrees  of 
response to both glucose and K+, due to the natural variation in physiological activity between the 
populations of islets.  It is clearly visible that, at the level used in this experiment (50 mM K+), 
high physiological glucose is a more potent stimulator of insulin release.  It is also interesting to 
note differences in the relative magnitudes of stimulation for the two effectors between groups of 
islets; while high glucose caused a similar insulin response for Figs. 4.10a and 4.10b, K+ 
stimulation for 4.10b is more than twice that seen in 4.10a, and likewise K+ stimulation is similar 
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Figure 4.10;  The results for the comparison of glucose stimulated (pink triangles) and K+ stimulated (purple 
triangles) insulin release from ~ 100 islets in three different MAMP channels during a single experiment. 
 
for 4.10a and 4.10c, but high physiological glucose resulted in nearly twice the insulin levels for 
4.10a than seen in 4.10c. 
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b. Continuous flow MAMP 
The MAMP can also be operated in a continuous flow mode, without a programmed 
flow/stop-flow cycle, like a traditional microfluidic device.  The flow/stop flow parameters were 
initially designed into the Cytosensor® Microphysiometer to improve the sensitivity toward 
changes in extracellular pH caused by H+ production.  The continuous flow experiment was 
designed with the hope that it would enable the detection of oscillatory production of insulin, 
which is not possible in flow/stop-flow mode where temporal resolution is traded for an increase 
in sensitivity.  
In initial control experiments, conducted without the inclusion of islets, it was observed 
that changing glucose levels affected the current response of the insulin sensor during continuous 
flow mode.  Fig. 4.11 shows the sensor response after baseline correction as the media is changed 
from low to high and back to low glucose again.  The difference in current for the two glucose 
levels was found to be 9.1 ± 0.9 nA.  In order to correct the contribution by glucose to the overall 
sensor response, a correction value was calculated from this current difference.  Since the 
difference in glucose concentrations between high and low glucose is 13.0 mM, this results in the 
addition of 0.7 ± 0.1 nA mM-1 glucose to the insulin sensor current.  
 
 
Figure 4.11;  Current response of the MWCNT/DHP sensor, after background subtraction, to a change in media 
glucose concentration from physiological low (2.8 mM) to high (16.7 mM) and back to low.  Current difference 
was 9.1 ± 0.9 nA. 
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Figure 4.12;  Results of a continuous flow MAMP experiment, showing the insulin levels [µM] generated by 
~ 100 islets in response to alternating physiologically high (16.7 mM) and low (2.8 mM) glucose concentrations  
 
The results of a live islet continuous flow MAMP experiment are presented in Fig. 4.12.  
This data has been baseline corrected and corrected for glucose interference for both low and high 
glucose levels.  The figure depicts a continuous flow experiment at a 4 µl min-1 flow rate with 
data collected at 1 sample per second.  Unlike the previous flow/stop-flow experiments (see 
previous section), insulin levels for the continuous flow experiment were calculated using a 
standard addition calibration (using 1 µM and 25 µM insulin) at the end of the experiment (not 
shown).  The first high glucose interval results in an insulin concentration of 24.2 ± 2.7 µM 
within the MAMP chamber, followed by a low glucose course resulting in a decrease of insulin 
levels to 16.3 ± 1.8 µM.  Returning the glucose to high levels results in a return to approximately 
the previous levels (25.8 ± 1.4 µM) for ~ 40 minutes, followed by a sustained higher production 
of insulin (33.2 ± 3.6 µM) for ~ 11 minutes (data not included on the graph).  The average insulin 
concentration throughout this high glucose course is 28.8 ± 4.4 µM.  The final decrease of 
solution glucose to the low physiological level results in a decrease of insulin to 20.6 ± 2.8 µM 
throughout the remainder of the experiment.  
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As previously mentioned, it was hoped that the continuous flow mode would enable the 
observation of oscillations in islet insulin exocytosis; monitoring of insulin oscillations is not 
possible in the flow/stop-flow mode.  High frequency insulin oscillations have been observed at 
intervals of 6 – 10 minutes, while low frequency oscillations have been documented at ~ 140 
minute intervals.14  A rudimentary analysis of the data presented in Fig. 4.12 presents two distinct 
possibilities for periodic insulin production.  Fig. 4.13 presents the same data as 4.12, but 
 
 
Figure 4.13;  Results of an FFT analysis of the continuous flow data, showing only noise in the area from 6 
minutes (10 hours-1) to 10 minutes (6 hours-1) where literature indicates high frequency insulin oscillations 
should occur. 
 
includes red traces representing pulsatile releases at periods of 20 minutes (left) and 14 minutes 
(right) respectively.  While the insulin release is clearly not completely due to pulsatile secretion 
at these intervals, they possibly represent at least a contribution to the observed insulin output. 
 
SECM Islet Experiments 
Topographical imaging was obtained in the form of a false color current profile, which 
was obtained by the inclusion of a redox mediator (FcTMA, E = + 0.65 V) in the supporting 
media.  Since FcTMA is not permeable to cell membranes76 the resulting current profile follows 
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the SECM principle for negative feedback, so that the current decreases as the UME probe gets 
closer to the islet.  The resulting topographical profile for one such islet is shown in figure 4.14a.  
The PSC trace above the false color image, equivalent to a cross section across the yellow line in 
the image, shows that the islet presents a roughly spherical profile, slightly flattened around the 
edges.   
Another benefit of the nature of the instrument is the possibility of using the same probe 
to detect multiple analytes by changing the tip potential.  In order to demonstrate this, after 
acquisition of the full topographical profile the probe potential was reset for oxygen reduction 
(Etip = − 0.5 V) and a second image was recorded (Fig 4.14b).  The current dips as the probe 
passes over the islet due to the depletion of oxygen in the surrounding media caused by 
mitochondrial respiration within the individual cells of the islet.  It can be seen that the oxygen 
 
 
Figure 4.14;  (a) A topographical 3D current profile map (FcTMA; Etip = + 0.65 V) and (b) oxygen respiration 
profile (Etip = - 0.5 V) for a pancreatic islet obtained with a Nafion coated 10 µm Pt UME. The topographical 
image (a) shows a roughly hemispherical shape and the respiration profile (b) is the approximate mirror image 
of (a), indicating uniform respiration throughout the islet.  The horizontal line across the profile depicts the 
direction and location of the PSC shown in the inset above each image.  Potentials reported vs. Ag/AgCl, 3 M 
KCl. 
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PSC (Fig. 4.14b, top) is roughly the inverse image of the corresponding topographical PSC (Fig. 
4.14a, top) for the same cross section of the islet, inferring a uniform respiration throughout the 
islet.  This is what would be expected since the mechanism for O2 transport across the cell 
membrane is passive diffusion.  In order to better demonstrate this, Fig. 4.15 depicts a false color 
current topographical image, with contour lines from a similar oxygen image overlaid on top.  
The oxygen current proceeds from low to high as the topography goes from high to low. 
 
 
Figure 4.15;  The contour lines of an SECM respiratory profile overlaid on the topographical image for the same 
islet, showing a uniform depletion of O2 in the media surrounding the islet.  The O2 concentration map is an 
inverse of  topography. Both images obtained with the same 10 µm Pt UME; for respiratory profile Etip = − 0.5 V 
and for topography Etip = + 0.65 V, both vs. Ag/AgCl, 3M KCl RE. 
 
 
Figure 4.16;  Three SPCs from an MWCNT/DHP coated UME sensor.  The bottom SPC (green) is a scan across 
a bare substrate away from an islet, the middle trace (blue) is above an islet at low physiological glucose (2.8 
mM), and the top trace (red) is the same cross section of the islet at high physiological glucose (16.7 mM). 
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In order to demonstrate the capability for detecting the insulin secretion from a live islet, 
the MWCNT/DHP sensor was utilized in a Bio-SECM within a cell culture dish containing a 
single pancreatic islet (HBSS, with low glucose), and a series of PSCs were performed (fig. 4.16).  
The sensor was first approached to the substrate surface, using the assistance of an inverted 
microscope.  In order to acquire a background image, the microscope stage was adjusted in the x-
y plane so that the sensor was away from the islet but remained close to the surface, and then the 
sensor was scanned across the bare dish surface.  The resulting background scan (4.16, green 
trace) shows only noise in the signal, as would be expected.  Next the microscope stage was used 
again to position the islet directly in the path of the sensor, and a second PSC was recorded (4.16, 
blue trace).  A slight insulin signal can be seen through the noise present at the center of the PSC, 
corresponding to the center of the islet.  Finally, the dish was spiked with a stock glucose solution 
from a micropipette to raise the concentration to the high glucose level, and the final PSC was 
recorded (4.16, red trace).  The triggered insulin release can be seen from the increase in signal 
between the blue and red traces. These UME sensors were then successfully able to not only 
detect insulin release by the islet, but more importantly were able to differentiate between the 
levels of insulin release at high and low physiological glucose levels.  
It should be noted that unlike human pancreatic islets, where the insulin producing β-cells 
are scattered throughout, murine islets contain all their β-cells at the center of the islet’s mass.77,78  
This explains the difference in the areas over which insulin could be detected at low and high 
glucose levels.  Since insulin is only secreted from the center of the islet, at low insulin 
production a smaller cross section of the PSC picks up the signal, while at high insulin production 
the increased insulin present diffuses outward.  
 
Conclusions 
The utility of the MWCNT/DHP sensor toward islet metabolism and studies of diabetes 
has been shown.  The robustness of the insulin sensor toward shear forces present in a 
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microfluidic environment was also demonstrated, with minimal interference from changes in 
glucose levels.  The sensor was shown to work in both traditional continuous flow microfluidic 
experiments and in flow/stop-flow MAMP experiments with equivalent sensitivity.  The 
MWCNT/DHP insulin sensor demonstrated adequate sensitivity with a limit of detection of 1 µM 
for the MAMP sensor and 200 nM for the UME sensor.  The MAMP sensor limit of detection 
was sufficient to detect changes in insulin exocytosis due to both glucose triggered and K+ 
stimulated insulin release, and resulting in a qualitative assessment of the effectiveness of those 
stimuli toward insulin production.  The effect of K+ stimulation on islet insulin secretion was 
found to be significantly less than that of glucose.  Also, the relative intensity of the insulin:K+ 
stimulation was found to vary from group to group of the islets observed.  Also the simultaneous 
collection of lactate production shows that metabolic rates of multiple cell types within an islet 
can be monitored simultaneously. 
The applicability of SECM toward the noninvasive exploration of single pancreatic islet 
metabolism has also been demonstrated.  The SECM was used to obtain topographical profiles, 
insulin release profiles, and cellular respiration profiles of single pancreatic islets.  Since 
pancreatic islets are true micro organs, composed of different cell types performing different 
biological tasks, the evaluation of their overall functionality is more complex than for single cells.  
The inclusion of analyte profiles for oxygen, which is indicative of overall cell viability, and 
insulin release, which is specifically indicative of β-cell activity, into assays for islet viability 
could result in a more complete evaluation of the overall functionality of the micro organ, 
especially in those islets destined for human transplantation.  While the SECM can not probe 
multiple analytes simultaneously, it is able to spatially as well as temporally differentiate data 
obtained from a live cell or organism.  While UMEs are currently limited to one electrode, and 
thus one analyte, this is not a concrete limitation, and as manufacturing techniques as well as the 
state of the art in imaging is improved, this limitation could be overcome as well. 
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CHAPTER V 
 
SINGLE CELL METABOLIC ANALYSES BY SCANNING  
ELECTROCHEMICAL MICROSCOPY* 
 
Introduction 
The past decade has witnessed a growth in the application of biosensors to micron and 
submicron level investigations in a wide variety of disciplines.  Rapid development, both in 
miniaturization techniques and in understanding of biological processes, has accelerated the 
expansion of biosensors in clinical applications and in areas such as biology, neurobiology, 
pharmacology, and tissue engineering.1,2  In this respect, researchers have been able to acquire 
real-time quantitative measurements through the application of micro-sensors on living cells, both 
in vitro and in vivo.2-4 
Of particular interest are the enzyme-based sensors because they offer the selectivity 
toward a single analyte optimized by natural evolution.  Enzymes achieve molecular recognition 
of substrates (i.e., analytes of interest) based on structural complementarity, leaving little room 
for error.5  Enzymes catalyze with high specificity chemical reactions in biological systems 
according to Equation 5.1: 
substrate + cofactor  productsenzyme→
    (5.1) 
Enzymes have been successfully employed in the miniaturization of sensor designs, including one 
of the most important sensors for the health industry that emerged decades ago: the glucose 
sensor which is based on glucose oxidase (GOx), whether it is intended for in vivo monitoring of 
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 glucose levels,6 or for a diabetic’s regular glucose meter for use at home.  BesidesGOx, there 
have been numerous other enzymes used for the development of miniaturized amperometric 
sensors, such as sarcosine oxidase,7 galactose oxidase,7 hexokinase,8 choline oxidase,7 lactate 
oxidase (LOx),9 alcohol oxidase,7 horseradish peroxidase,10 cholesterol oxidase,11,12 etc.  In 
addition to their importance for diabetes patients and in vivo studies, enzyme-based amperometric 
sensors are irreplaceable tools for the non-invasive study of the metabolism at the cellular level.  
A simplified view of the metabolic processes at the single cell level is presented in Fig. 5.1, 
indicating that information about the way a cell performs glycolysis could be acquired by using 
enzyme-based sensors for glucose and lactate.  We have already employed GOx and LOx based 
sensors for probing cellular metabolism in a multianalyte microphysiometer  
 
 
Figure 5.1; Cancer cell metabolic pathways suitable for electrochemical probing by SECM.  Cancer cells have 
an altered metabolism compared to normal cells, with glycolysis being one of the affected pathways. TCA = 
tricarboxylic acid cycle. 
 
 (MAMP).13-16  Our laboratory has modified the CytosensorTM microphysiometer (originally 
developed by Molecular Devices for the measurement of acidification rates) into the MAMP to 
allow for simultaneously recording four analytes: glucose and oxygen uptake, lactate production 
and extracellular acidification rates for large numbers (> 105) of cells.  The MAMP proves a 
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useful tool in studies such as the response of various cell types to chemical agents and toxins with 
ramifications in biodefense studies;15 cancer cellular metabolism relating genetic mutations to 
different metabolic phenotypes, with implications in mathematical modeling of cancer.17,18  The 
MAMP yields metabolic rates (e.g., lactate production rate) for large number of cells, but has no 
ability to assess cell to cell variability.  This paper is not a study of the variability of metabolic 
rates from one single cell to another, but rather it presents the technical means that could be 
employed for addressing this problem by opening up the range of analytes for single cell 
electrochemistry.  
 
 
Figure 5.2;  Enzyme-based UME biosensor.  Enzyme layer (GOx (a) or LOx (b)) is deposited onto 25 µm Pt 
UME by either electropolymerization or casting.  The tip is rastered across the cell adhered to a Petri dish: a) in 
the case of GOx it senses extracellular glucose depletion due to cellular uptake; b) in the case of LOx it senses 
lactate production by the cell.  The enzyme film breaks down the analyte, and the resulting H2O2 is oxidized at 
the underlying Pt UME.  The arrows entering the cell symbolize glucose uptake (a), while the arrows exiting the 
single cell denote lactate production (b). 
 
The glucose and lactate amperometric sensors are based on a Pt electrode that is in 
contact with a polymer containing the specific enzyme (Fig. 5.2); glucose and lactate are 
measured indirectly at the electrode surface by amperometric oxidation of hydrogen peroxide.  
The hydrogen peroxide is formed in aqueous environments during the reaction catalyzed by the 
enzyme entrapped in the matrix (e.g., GOx in Fig. 5.2a or LOx in Fig. 5.2b) with the analyte of 
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interest (i.e., glucose for Fig. 5.2a or lactate for Fig. 5.2b) in aerobic conditions, as described by 
Equations 5.2 and 5.3: 
D- D-glucose  oxygen  gluconolactone  hydrogen peroxideGOx+ → +
  (5.2) 
L-lactate  oxygen  pyruvate  hydrogen peroxideLOx+ → +
   (5.3) 
Horrocks et al.10 have used an enzyme (horseradish peroxidase) UME in conjunction with 
the scanning electrochemical microscopy (SECM) for the measurement of H2O2 at surfaces.  
They do not present any amperometric approach curves (ACs), but rather conductance-distance 
curves.  The conductance measurements have the advantage of being insensitive to the enzyme-
polymer layer present on the tip, however, they have to be performed in solutions of very low 
conductivity (1 mM KCl) which makes them unsuitable for physiological applications, such as 
approaching and imaging in biological buffers (e.g., RPMI).  Kueng et al.8 have also reported the 
use of an enzyme UME for SECM; they have assembled a Pt dual microdisk electrode with one 5 
µm Pt for electrode positioning via ACs and with the other 5 µm Pt modified through 
electropolymerization with both GOx and hexokinase for indirect imaging of ATP transport 
through a porous polycarbonate membrane.  However, they have not used the enzyme sensor of 
this dual UME for either approaching the surface nor for imaging of live organisms.  Acquiring 
ACs using the electrochemical process that takes place at an enzyme modified tip would remove 
the need in this case for manufacturing the more complicated dual UME.  Kueng et al.19 have also 
used an enzyme (GOx) coated tip integrated in an AFM-SECM setup for imaging glucose 
transport through a porous membrane; in this case they bypassed the need for ACs by using the 
AFM tip. 
SECM20-23 can be developed as a useful technique for the study of cell metabolic fluxes 
(as an important component of metabolomics), since it can map electrochemical activity across 
the entire surface of a single cell, and can record dynamic changes.  Although SECM has been 
used over the years for investigating biological systems,23,24 only recently has attention been 
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given to SECM for single cell studies.25-38  Mirkin et al.26,27,32-34 have investigated single cells by 
SECM in order to determine various redox activities across different types of cells, examining the 
differences between nonmetastatic and metastatic human breast cells.  They have identified series 
of redox mediators that can cross the cell membrane, investigated their distribution between 
cytosol and nucleus, and found them unable to penetrate the nuclear envelope.  Matsue et al.36-38 
studied single cell topography and paid particular attention to respiration studies by means of 
SECM for cells such as protoplasts and PC12.  Wipf et al.31 have used SECM to monitor the real-
time morphological changes in PC12 cells that are used as model neurons.  Baur et al.30 have used 
a constant distance SECM for a study of PC12 cells where they showed that constant impedance 
imaging yields superior topographic images of single cells compared to more common constant 
height SECM.  Schuhmann et al.28 recorded topographic images of PC12 cells by SECM, and 
studied catecholamine release from PC12 cells, using SECM as a positioning tool for an 
amperometric sensor in the vicinity of the cells.  Isik and Schuhmann29 have detected the release 
of nitric oxide from single T-HUVEC cells by also using a constant distance SECM.  Bard et al. 
have used SECM to study the metabolism of menadione to thiodione in single hepatoblastomas,35 
and have probed the activity of HeLa cells using the oxidation of a ferrocene derivative.25 
Our choice of using the constant height SECM versus the constant distance SECM for the 
study of single cell metabolism was predicated on using a chemically modified tip (i.e., Pt UME 
coated with an enzyme-containing polymer); the modified tips can be integrated easier with the 
typical constant height SECM mode of operation.  The major ways of achieving the constant 
distance mode in SECM are all relatively limited for the distance signal  possibilities, due to their 
intrinsic design.  One possibility for the constant distance mode is the use of the impedance 
SECM,39 which is based on acquiring data based on high frequency capacitance measurements.  
The capacitance of the chemically modified tips would be dramatically affected by the presence 
of the polymer layer entrapping the enzymes on the Pt UME, compared to bare metal tips.  
Another way of achieving the constant distance mode for SECM measurements is by using shear 
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force.40  Hengstenberg et al. have shown that enzyme-filled capillaries can be used as tips for 
scanning using a shear force based constant distance SECM mode;41 however, these tips are not 
amperometric and are suited to generation-collection modes, not imaging.  The application of a 
polymer film to the tip for shear force based SECM applications appears technically challenging 
because the mass loading of the enzyme film will reduce the resonant Q of the oscillating tip in 
addition to the hydrodynamic loss in Q from a large volume of solution above the cells.  Another 
mode of operation for the SECM would be the AFM-SECM.42  While Kueng et al. reported a 
GOx-coated AFM tip,19 the use of AFM-SECM for scanning live cells has yet to be developed 
into a practicable method, and the difficulty of making each tip by FIB micromachining is 
considerable.  The integration of polymer film-modified tips for use in conjunction with a 
constant distance SECM for the study of live cell metabolism will be the subject of future studies.  
With the typical UME sizes of 5-25 µm used in our work, the higher resolution possible by 
constant distance control would not be significant, justifying our use of constant height imaging. 
A single cell is the basic structural and functional unit of all organisms.  While the 
MAMP provides information about the metabolism of cells, it averages signals over large 
populations (> 105 cells) and cannot distinguish differences between individual cells.  One cannot 
develop a deep understanding of metabolomics unless the processes are explored in the context of 
the individual cell level, wherein multiple biochemical processes, distributed throughout the cell 
and various cell compartments, are integrated into a functional system.  Differences in the 
average rate of glycolysis between large numbers of cancerous and healthy cells have been 
demonstrated,43,44 making spatio-temporal mapping of glycolytic analytes (e.g., pH, lactate, 
oxygen, glucose) an area of great interest.  The intracellular pH for both cancerous and normal 
cells is approximately 7.4,45 and the extracellular pH for cancerous growths is acidic, with values 
as low as 6.7.46  This increased acidity in tumors is a result of the Warburg effect,44 i.e., enhanced 
glycolysis, which under hypoxic conditions leads to an increased lactate production that in turn 
lowers the extracellular pH (see Fig. 5.1).  Walenta et al.47 reported mean lactate concentrations in 
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head and neck tumours of ~ 12 µmol/g, as compared to similar normal tissue lactate 
concentrations of ~ 5 µmol/g.  Acidity profiles32 were previously studied by SECM for single 
living cells; however, the recording of these pH profiles presents certain technical difficulties, 
such as the use of an additional potentiostat in conjunction with the SECM, as the pH sensor (Sb-
based in Liu et al.’s paper)32 is by definition potentiometric.  Using the lactate production to 
characterize cancer cells presents its own advantages, such as the use of an amperometric sensor 
for lactate sensing, the ability to record lactate profiles in highly buffered solutions (as most cell 
culture media are) as opposed to a pH potentiometric sensor that can be used solely in a modified 
low buffered medium.  Lactate production profiles could also provide information that could lead 
to a deconvolution of the pH profiles of cancerous cells. 
Cell respiration37 was also previously studied by SECM for single living cells; however, 
to our knowledge, there have been no reported glucose or lactate spatio-temporal profiles for 
single live cells.  We present in this paper the manufacturing and characterization of glucose and 
lactate ultramicroelectrode biosensors for SECM of single live cells, and demonstrate that the 
GOx-based sensors can be used for the positioning of the UME in the vicinity of the cell, as well 
as for the imaging of the cell, and also show that the LOx-based sensors can be used for recording 
of lactate release profiles from single cells. 
 
Experimental 
Materials   
The materials were purchased as follows: MgCl2 . 6H2O, NaH2PO4 . H2O, HCl, CaCl2, 
MgSO4, NaCl, KCl, KH2PO4, NaHCO3, L-lactic acid, sodium acetate trihydrate, 35 mm Petri 
dishes and 50 mM phosphate buffer pH 7.0 from Fisher Scientific; KPF6 from Aldrich Chemical; 
glutaric dialdehyde as 25% solution in water (GDA) and 2-aminophenol (OAP) from Acros; 
Na2HPO4 . 7H2O, bovine serum albumin (BSA), RPMI 1640, D-glucose, GOx, type II-S from 
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Aspergillus niger and LOx from Pediococcus species from Sigma; H2SO4 and NaOH from EM 
Science; ethanol (absolute proof) from Aaper; ferrocenylmethyltrimethylammonium iodide from 
Strem Chemicals; N2 from Gibbs Welding Supply; conductive silver epoxy from Epoxy 
Technology; white sealant Hysol Epoxi-Patch from Dexter Corporation; 35 mm glass bottom 
Petri dishes from Bioscience Tools.  All materials were used as received unless otherwise 
specified. 
ASTM Type I (18 MΩ) analytical grade deionized water (DI) was obtained with a 
Solution 2000 Water Purification System from Solution Consultants.  All solutions were filtered 
prior to use with 0.2 µm syringe filters from Fisher.  Ferrocenylmethyltrimethylammonium 
hexafluorophosphate (FcTMA) was prepared according to the method of Mirkin and co-
workers.48  All reported potentials were measured against a commercial Ag/AgCl, 3 M KCl 
reference electrode (RE, model CHI111, CH Instruments). 
 
SECM of unmodified UMEs   
All SECM measurements were conducted with a CHI900 instrument from CH 
Instruments equipped with an adjustable stage for tilt correction.  The electrochemical cell was in 
a typical four-electrode configuration for testing the UMEs: UME tip electrode (working 
electrode, WE), Pt wire counter electrode (CTR), Ag/AgCl, 3 M KCl (RE), and substrate 
electrode (SE), which was a 2 mm Pt disk (CHI303).  All UMEs were manufactured with 5 or 25 
µm Pt wire from Goodfellow according to Bard et al.,21 polished with 0.05 µm alumina from 
Buehler, and sonicated in ethanol and water.  UMEs were electrochemically cleaned for 5 min in 
0.5 M H2SO4 using a CHI660a potentiostat, and were tested with 1 mM FcTMA in 100 mM KCl 
for performance.  The Pt SE was polished and cleaned in an identical manner to the UMEs.  Only 
UMEs capable of achieving IT = 8 (e.g., 800% increase in current over steady-state conditions far 
from the SE)23 during approach to the Pt SE were used in biosensor construction.  The UMEs 
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were also characterized by cyclic voltammetry (CV), and consistently yielded the expected 
sigmoidal CV.  The UMEs used had RG ratios21 of ~ 5 for the 5 µm Pt tips (7 µm actual 
measured diameter) and ~ 2 for the 25 µm Pt tips. 
 
Enzyme-modified UMEs 
a.  Manufacturing.   
The enzyme-containing polymer layer was deposited onto 25 µm Pt UMEs via two 
distinct methods: (i) Electropolymerization – the enzyme was deposited on the electrode in a 
similar manner as described by Zhang et al.49  The enzyme (10 mg/mL for GOx and 2 mg/mL for 
LOx) and the OAP (0.8 mg/mL) were dissolved in 50 mM acetate buffer, pH 5.9, the solution 
was degassed (N2), and the electrodeposition occurred under stirring at E = +0.65 V vs. Ag/AgCl, 
3 M KCl for 1 hour (CHI660a workstation equipped with a Faraday cage); the electrodes were 
allowed to dry for another hour, were then briefly rinsed with DI and stored at 4 oC in 50 mM 
phosphate buffer until use.  (ii) Casting – the enzyme (8 mg/mL for GOx and 10 mg/mL for 
LOx), GDA (14 µL/mL buffer) and BSA (62.5 mg/mL) were all dissolved in 50 mM phosphate 
buffer, pH 7.0;16 the enzyme solution was then hand-cast onto the surface of the UME by briefly 
touching the tip of the UME to a tiny droplet of enzyme solution; the UMEs were air dried and 
stored at room temperature until further use.   
b. Calibration   
The performance of the biosensor UMEs was tested using a CHI660a potentiostat with a 
three electrode configuration: WE – enzyme UME; RE - Ag/AgCl, 3 M KCl; CE – Pt mesh.  
Current vs. time curves were recorded under moderate stirring at E = + 0.6 V vs. Ag/AgCl, 3 M 
KCl (for both GOx and LOx).  Standard additions were made from stock solutions of 500 mM 
glucose and 100 mM lactate.  To ensure the validity of the results, the calibrations were 
performed before and after the use of the biosensor UMEs in conjunction with the SECM.   
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SECM approach curves of biosensor UMEs   
ACs were acquired for GOx and LOx UMEs in a three-electrode system: WE – biosensor 
25 µm UME; RE - Ag/AgCl, 3 M KCl; CE – Pt mesh.  The tip was approached to the substrate 
(35 mm Petri dish) and allowed to touch it.  Glucose solutions of 1.0-5.0 mM and lactate 
solutions of 0.5 mM were used in the approach experiments. 
 
Cell culture  
Fibroblasts (mouse fibroblast CRL-10225) were cultured in high glucose (4.5 g/L) 
DMEM (Dulbeco's modified Eagle's medium) with 4 mM L-glutamine, supplemented with 10 % 
fetal bovine serum and 1.0 mM sodium pyruvate.  MCF10CA1a cells50 were cultured in 
DMEM/F12 medium, supplemented with cholera toxin (0.1 µg/mL), insulin (10 µg/mL), 
hydrocortisone (0.5 µg/mL), epidermal growth factor (20 ng/mL) and horse serum (5 %).  PC12 
cells (CRL-1721) were cultured in Ham's F12K medium with 2 mM L-glutamine adjusted to 
contain 1.5 g/L sodium bicarbonate (82.5 %), horse serum (15 %), and fetal bovine serum (2.5 
%); PC12 cells were plated on dishes treated with human collagen (type IV). 
 
SECM imaging   
The SECM was used in conjunction with an inverted microscope (VistaVision, VWR) 
equipped with a stage and objective warmer (TCII, 2Ch micro temperature controller, Bioscience 
Tools).  The inverted microscope allowed for visually monitoring the morphology of the cells to 
be scanned.  The SECM tip holder was extended above the microscope objective with the aid of a 
light but sturdy aluminum piece.  For positioning, the UMEs were approached to the dish and 
then withdrawn a known distance.  The data were recorded in a three-electrode system: WE – 
UME; RE - Ag/AgCl, 3 M KCl; CE – Pt mesh, in the constant height mode.   
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a. Glucose profiles.   
The 25 µm UME GOx biosensors were positioned near the cell to be imaged, and then 
the biosensor tip was rastered across the surface above the cell while the tip was maintained at 
E = + 0.6 V vs. Ag/AgCl, 3 M KCl.  The buffer used was Hank’s balanced salt solution (HBSS), 
pH 7.4, 5 mM glucose and no phenol red.   
b. Lactate profiles  
 The 25 µm UME LOx biosensors were positioned near the cell to be imaged, and then 
the biosensor tip was rastered across the surface above the cell while the tip was maintained at E 
= + 0.6 V vs. Ag/AgCl, 3 M KCl.  The buffer used was RPMI, pH 7.4; there was no lactate 
added/present in the solution.  There are possible interfering analytes secreted by the cells (e.g., 
peroxide, dopamine, etc.) that would be active at the potential set for the UME biosensor.  
However, the types of sensors we are using are enzyme-based, and the polymer films are highly 
selective, as the polymer helps to block interferents.  We have extensively tested the use of the 
sensors in the presence of live cells in the MAMP and found no analyte detection problems due to 
cross-interferents at this potential.14-16   
c. Oxygen profiles   
The buffer used was HBSS, pH 7.4, with 5 mM glucose and 1 mM FcTMA.  The Pt 7 µm 
UME was used for recording topographical images first, with the tip potential E = + 0.6 V vs. 
Ag/AgCl, 3 M KCl, ensuring the oxidation of the FcTMA.  We chose FcTMA as mediator for 
topography imaging of single cells based on previous work in our lab showing that this particular 
redox mediator does not cross bilayer lipid membranes (BLMs),51 i.e., it yields a negative 
feedback when the UME approaches the BLM.   Once the SECM topography information was 
acquired, the tip potential was switched to E = - 0.5 V vs. Ag/AgCl, 3 M KCl, ensuring the 
reduction of the oxygen present in the solution, thus yielding oxygen uptake profiles. 
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Results and Discussion 
We have manufactured GOx enzyme UME biosensors by employing two methods: 
electropolymerization and hand casting.  We have tested the properties of the enzyme films 
deposited onto the Pt UMEs by doing amperometric calibrations prior to any SECM applications.  
Figure 5.3a displays a typical example of a calibration toward the analyte of interest (i.e., 
glucose) of an electropolymerized GOx UME biosensor.  The sensor displays linear sensitivity to 
glucose for concentrations of up to 18 mM, and there is no response to blank additions (buffer, no 
glucose).  In order to find the “zero distance point” on the AC, the sensors were allowed to 
approach until they physically touched the substrate surface.  In order to determine whether the 
procedure adversely affected performance, after the SECM experiments the sensors were tested 
again for sensitivity with respect to their analyte.  Figure 5.3b shows an example of amperometric 
calibration for a GOx UME sensor after use in conjunction with SECM for recording ACs.  The 
sensor UME continues to display linear sensitivity to glucose for concentrations of up to 18 mM, 
and there is no response to the blank additions.  Comparatively, the cast GOx UME biosensors 
display a narrower linear sensitivity range, for glucose concentration of up to 14 mM.  Figure 
5.3c presents the stability of an electropolymerized GOx UME sensor in time.  The data points in 
Figure 5.3c have been obtained from amperometric calibration curves similar to the ones 
presented in Figures 5.3a and 5.3b.  Figure 5.3c displays one measurement (data point) for each 
day for each concentration represented on the graph.  The electrode was stored in the refrigerator 
in 50 mM phosphate buffer pH 7 between runs.  There is little difference between the calibrations 
done over the course of 12 days, and this minute variation is not important in the context of the 
fact that the electrodes should always be calibrated the day of the measurements.  The 
electropolymerized GOx sensors (if stored at 4 °C in buffer) preserve their sensitivity toward 
glucose for periods of time for up to 1 month.  In contrast, the cast 25 µm GOx sensors (stored at 
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Figure 5.3;  Amperometric calibrations of electro-polymerized GOx 25 µm UME biosensors,  E = + 0.6 vs. 
Ag/AgCl, 3 M KCl; additions up to 18 mM glucose in 50 mM phosphate buffer, pH 7: a) GOx UME sensors 
exhibit sensitivity to glucose prior to SECM experiments; b) the sensors preserve the sensitivity to their analyte 
after being employed in extensive SECM experiments; c) the electropolymerized GOx biosensors are stable in 
time when stored in 50 mM phosphate buffer, pH 7 at 4 oC for periods of at least two weeks; same sensor shows 
almost identical sensitivity after 1, 10 and 12 days from electropolymerization date.  The data presented in this 
figure is for three distinct electropolymerized GOx sensors (one sensor for the data in (a), one sensor for the data 
in (b), and another sensor for the data in (c)). 
 
room temperature, no buffer) start to lose sensitivity to glucose after 2-3 days.  Different storage 
conditions have been explored for all types of sensors presented in this paper, and the optimum 
ones for each sensor type are the only ones discussed here (dry storage at room temperature for 
hand-cast biosensors, and 4 °C in buffer for electropolymerized biosensors).  One advantage that 
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the cast GOx sensors have over the similar electropolymerized ones is the more facile 
manufacturing procedure, which renders the films applied on the 25 µm Pt UME as ‘disposable.’  
The overall success rate for production of sensors (determined by whether sensors exhibited 
sensitivity toward their analyte the same day as manufacturing) was ~ 70 % for the 
electropolymerization process and ~ 90 % for the casting method (we have tested at least 20 
electrodes for each method). 
The lactate sensor production is complicated by the relatively lower stability of LOx as 
compared to GOx.  Fig. 5.4 compares the behavior of electropolymerized and cast LOx UME  
 
 
 
Figure 5.4;  Amperometric calibrations of a) electropolymerized and b) cast LOx 25 µm UME biosensors,  E = + 
0.6 vs. Ag/AgCl, 3 M KCl; additions up to 1 mM lactate in 50 mM phosphate buffer, pH 7.  The sensors were 
calibrated for concentrations of up to 1 mM lactate, and display two distinct linear regions: below 0.3 mM and 
above 0.4 mM, with the expected cellular lactate release range below 0.3 mM.  The sensors retain lactate 
sensitivity upon being used in SECM experiments.  Double reciprocal plot representations of these 
amperometric calibrations: c) the electropolymerized LOx sensor for which the corresponding data is shown in 
a); and d) cast LOx sensor for which the corresponding data is shown in b) – before use in SECM. 
107 
 
sensors.  For both types of LOx-based sensors, the calibration plots seem to exhibit two distinct 
linear ranges: 0.1 – 0.3 mM that covers the likely physiological range for single cell release, and 
0.4 – 0.9/1.0 mM lactate, which may be useful for future studies (e.g., scanning across surfaces 
with patterned LOx, in the presence of lactate in solution).  Horrocks and co-workers10 have 
observed the same type of dual range when they calibrated a horseradish peroxidase-modified 
UME with respect to H2O2 sensitivity; they have proposed that this decay in sensitivity was due 
to the redox process in parts of the polymer in poor contact with the UME element (carbon fiber 
in their case).  The electropolymerized LOx sensors generally lose sensitivity to lactate above 0.9 
mM lactate (Figure 5.4a).  However, these UME sensors are assembled with the help of oxidases, 
and as such they should obey the enzyme kinetics laws.  For enzymes following the Michaelis-
Menten behavior, one should look at the Lineweaver-Burk double reciprocal plot, where the 
inverse of the reaction rate is directly proportional to the inverse of the substrate concentration5 
(e.g., lactate in our case).  Since the reaction rate is directly proportional to the current,52 we can 
plot the inverse of the current versus the inverse of the lactate concentration, for example, and if 
the plot is linear, then the enzyme follows the Michaelis-Menten kinetics.  Figure 5.4c displays 
the data from Figure 5.4a in the form of the Lineweaver-Burk double reciprocal plot, and Figure 
5.4d does the same thing for the data from Figure 5.4b (before SECM).  Both plots appear linear, 
indicating that the presence of two distinct regions in Figures 5.4a and 5.4b are due to a saturation 
of the LOx enzyme with the lactate substrate, meaning that the enzymes follow the Michaelis-
Menten kinetics.  The R2 values for the Lineweaver-Burk double reciprocal plots in both cases 
(Figures 5.4c and 5.4d) are higher than the R2 values for the linear ranges corresponding to the 
higher concentrations (> 0.4 mM, Figures 5.4a and 5.4b), indicating that these films should be 
regarded as obeying the Michaelis-Menten behavior, rather than having two distinct linear 
regions as it was previously suggested.10  Since the concentration of lactate production by cells is 
very low, the concentrations of produced lactate are contained in the lower regions (below 
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0.3 mM lactate), which are linear under the Michaelis-Menten behavior, and thus the enzyme 
saturation with the substrate does not hinder the detection for our purposes.  
Just as for the GOx UME biosensors, we have tested the properties of the LOx sensors 
before and after the use in conjunction with the SECM, to validate the SECM results.  Figure 4B 
displays examples of calibration plots for a cast LOx UME biosensor in the lower linear 
concentration range before and after recording ACs (where the tip was allowed to touch the Petri 
dish substrate in order to find the “zero distance point”), showing that sensitivity toward lactate is 
retained.  While the electropolymerized LOx sensors are more reproducible, they have a lower 
life time (~ 24 h, stored at 4 oC in buffer) compared with the cast LOx sensors (2 days, room 
temperature).  The manufacturing success rate is overall lower for the LOx sensors than for the 
GOx sensors: ~ 20 % for electropolymerized LOx and ~ 60 % for cast LOx sensors (we have 
tested at least 20 electrodes for each method).  Just as in the case of the GOx sensors, the cast 
LOx sensors are easier to manufacture than the electropolymerized ones, and the cast LOx films 
can be regarded as ‘disposable.’ 
As expected, for both types of sensors discussed in this paper, the electropolymerized ones 
were more reproducible than the cast ones.  During the casting procedure it is difficult to control 
the exact amount of enzyme solution that gets deposited onto the Pt tip and/or the casting solution 
homogeneity (for electrodeposition the solution is stirred).  However, individual sensor 
calibrations must be performed prior to use, making this less important.  Figure 5.5 presents ACs 
for two distinct electropolymerized GOx UME sensors manufactured a few months apart (both 
tested the second day after manufacturing, approaching to plastic Petri dishes) and illustrates 
overall reproducibility of the electropolymerization manufacturing process.  We can compare the 
ACs since we have the ‘zero separation distance’ for each curve, and currents have been 
normalized with respect to their steady-state current values.  For the sensor #2 in Fig. 5.5a the 
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Figure 5.5;  Approach curves for 25 µm UME enzyme-based biosensors; E = + 0.6 vs. Ag/AgCl, 3 M KCl; in 50 
mM phosphate buffer, pH 7: a) GOx electropolymerized sensors #1 (approach speed 1.5 µm/s) and #2 (approach 
speed 3 µm/s) yielded similar curves in 5 mM glucose, indicating reproducibility; b) GOx cast sensor (5 mM 
glucose, approach speed 3 µm/s); c) LOx cast (0.5 mM lactate, approach speed 15 µm/s).  In all plots the vertical 
dashed line represents the point where the UME tip touches the Petri dish, coming from the right side (solution 
side). 
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current increases upon the tip touching the substrate; this is probably due to a slight compression 
of the polymer layer which in turn could cause a sudden increase in the concentration of 
electroactive species at the Pt sensing element.  Figures 5.5b and 5.5c display ACs for cast 
electrodes: GOx and LOx cast UME biosensors, respectively.  For the case of GOx-based sensors 
the ACs can be used as means of positioning the tip at a known distance from the substrate when 
imaging live cells for example (since the solution contains glucose needed for cell viability).  In 
the case of metabolic lactate imaging, there is insufficient lactate in the extracellular solution 
(e.g., produced by a single cell, since the solution has no added lactate) to allow an AC to be 
performed, although there might be other applications where the lactate approach curves might 
find use (e.g., study of LOx kinetics).  Upon conducting an extensive review of the literature we 
were unable to find any published studies featuring ACs generated by enzyme electrodes, 
therefore Figure 5.5 presents the first amperometric ACs recorded with enzyme coated UMEs.  
The ACs for the enzyme-coated UMEs do not obey the classic SECM feedback theory, due to the 
presence of the polymer layer deposited on the Pt surface.  The attempts of fitting the ACs to the 
simple kinetically limited (and/or mass transfer limited) feedback modes for SECM did not 
succeed either, pointing to the fact that the processes occurring at the tip are complex, and this 
opens the door to future studies for unfolding the intricacies of enzyme coupled electrode kinetics 
for these UME sensors. 
We have used the ACs for the GOx UME sensors to position the tip at a certain distance 
(10 µm) from the glass bottom Petri dish on which fibroblasts were cultured at low density (2000 
cells in the entire dish) to permit the imaging of a single fibroblast without interference from 
neighboring cells.  We have used both the visual monitoring of the enzyme UME approaching the 
surface of the Petri dish with the help of the inverted microscope, and the ACs to find the point 
where the tip touches the substrate.  The problem with only physically lowering the tip onto the 
surface of the substrate37 is that the tip can be damaged in the process.  By using the ACs in 
conjunction with the optical monitoring of the moving tip, we minimize the opportunities for 
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damaging the sensor.  Upon establishing physical contact between the tip and the substrate, the 
tip is retracted the desired distance using the z-axis inchworm of the SECM setup, and 
consequently the tip-substrate separation distance that we report for the cell imaging is as 
accurate as the movement of the z-axis inchworm.  While it is possible that the polymer layer 
would slightly adhere to the surface of the dish and the geometry of the enzyme film would be 
slightly disturbed in the retraction movement, our calibration experiments (see Figs. 5.3 and 5.4) 
clearly indicate that the analyte sensitivity of the UME biosensor is not altered upon recording 
ACs and gently touching the surface of the substrate.  Upon positioning the UME biosensor at the 
desired distance above the Petri dish, the tip is rastered across the live cell while monitoring its 
movement through the optical microscope.  Figure 5.6 shows the results of such an experiment, 
revealing a glucose uptake profile above a single fibroblast from a background solution 
containing 5 mM glucose.  The current is the lowest on the top of the cell (as expected) and the 
uptake profile is uniform.  The glucose uptake profile above a single fibroblast looks similar to 
the topography profiles of single fibroblasts.  It is possible that the glucose uptake observed here 
is a combination of both diffusion/distribution profile of glucose around the fibroblast and  
 
 
Figure 5.6;  Glucose uptake profile for a single fibroblast.  E = + 0.6 vs. Ag/AgCl, 3 M KCl; 5 mM glucose in 
HBSS, pH 7.4; scanning speed 15 µm/s; tip: GOx cast film on 25 µm UME biosensor; d = 10 µm from Petri dish; 
data have been corrected for background tilt in Origin Pro 7.5.  The GOx cast 25 µm UME tip was positioned at 
10 µm from the Petri dish by using approach curves. 
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nutrient uptake by the cell.  Consequently, for the study of cell metabolism one should acquire 
glucose uptake images in conjunction with measuring the cellular production of an analyte, such 
as lactate. 
 
 
Figure 5.7;  Lactate production from a single cancer cell MCF10CA1a.  E = + 0.6 vs. Ag/AgCl, 3 M KCl; no 
lactate added in RPMI media, pH 7.4; scan speed 3 µm/s; tip: LOx cast film on 25 µm UME biosensor; red line: 
lactate production current associated with a single MCF10CA1a cancer cell; blue line: in the same Petri dish, 
same electrode, scan across surface when no cancer cells are present in the path of the electrode; data have been 
corrected for background tilt in Origin Pro 7.5. 
 
One of the hallmarks of cancer cells is a lowered extracellular pH which is in part due to 
increased anaerobic respiration and lactate production by the cell (see Fig. 5.1).  We have picked 
for this study an invasive cell line (MCF10CA1a) that forms tumors and metastasis in mice.50  
Figure 5.7 represents lactate production by a single MCF10CA1a cell, as sensed by a cast LOx 
25 µm UME tip.  The onset and falloff of current during the scan was observed (via the inverted 
microscope) to coincide with the period when the UME sensor was physically above the cell.  
The topography of the MCF10CA1a cells is hemispherical; however, because the lactate is 
produced by the cell (as opposed to being consumed, as in the case of glucose uptake), an 
increase in the lactate concentration above the cell is a consequence of cellular activity, and it 
cannot be mistaken for changes in cellular topography.  The overlaid background curve was 
generated by repeating the scan, at the same tip-substrate separation, in a region of the dish where 
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no cells were present.  We chose the control experiment of scanning above the bare surface of the 
Petri dish in order to prove that unless there is a source for the lactate (i.e., MCF10CA1a cell in 
our case), no current increase will be observed.  
 
 
 
Figure 5.8;  Topography (a and c) and oxygen uptake profile (b and d) of a single PC12 cell.  E = + 0.6 vs. 
Ag/AgCl, 3 M KCl for topography and E = - 0.5 vs. Ag/AgCl, 3 M KCl for respiration; 1 mM FcTMA in 
Ringer’s solution pH 7.4; tip: Pt 7 µm UME and scanning speed 30 µm/s for both images; data have been 
corrected for background tilt in Origin Pro 7.5.  The tip was positioned by ACs to the insulating Petri dish 
surface: d ~ 10 µm from Petri dish for topography and d ~ 8 µm from Petri dish for respiration.  (a) and (b) 
display the 3D contour plots for topography and respiration respectively.  (c) and (d) are the same images from 
(a) and (b) with ‘crosshairs’ for easier comparison of the topography and respiration profiles: horizontal 
crosshair corresponds to the scan presented above the image; vertical crosshair corresponds to the scan 
presented on the right side of the image.  All distances are in µm. 
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Cancer cells present enhanced aerobic glycolysis44 and thus oxygen is an important 
analyte (see Fig. 5.1) that has to be accounted for when the metabolic profiling of cancerous cells 
is sought.  We have recorded topographical images of PC12 cells in a medium containing 
FcTMA, with the potential of the 7 µm Pt UME tip set at E = + 0.6 vs. Ag/AgCl, 3 M KCl; at this 
potential the FcTMA present in solution gets oxidized at the Pt tip and a topography-type profile 
is observed, corresponding to the amount of FcTMA available for immediate diffusion to the tip, 
i.e., corresponding to the distance between the tip and the imaged object (PC12 cell in this case).  
An example of PC12 topography can be observed in Figure 5.8a, where the 3D contour plot for 
the FcTMA oxidation profile around the cell is presented.  The shape of the cell appears uniform, 
as a hemispherical object.  Upon obtaining information about the cell surface, we have switched 
the potential of the same Pt tip to E = - 0.5 vs. Ag/AgCl, 3 M KCl, to ensure the reduction of the 
oxygen present in solution at the Pt UME, and we have scanned the same area and obtained a 
respiration profile of the same single PC12 cell as it can be seen in Figure 5.8b.  It is very 
interesting to observe that the oxygen profile we recorded across the cell does not mirror the 
topography.  Takii et al.37 reported that the acquired respiration image identically matched the 
expected topography (profile of the oxygen diffusion hindrance atop the cell, i.e., the oxygen 
distribution around the cell) and they were not able to show distinctive oxygen uptake profiles. 
While we have acquired images (taken at d ≈ 10 µm from the dish surface, not shown) 
that resemble the previously published cell respiration images as cell topography, when the tip is 
scanned closer than 10 µm to the surface, it is possible to obtain images that allow differentiation 
in respiratory activity as a function of spatial location.  Since the diffusion of the oxygen is 
extremely rapid in aqueous solutions, it is important to approach closer to the cell, so that the 
image obtained (E = - 0.5 vs. Ag/AgCl, 3 M KCl) is not solely the result of the cell topography, 
but includes oxygen uptake concentration profiles.  We have recorded a respiration profile at d 
~ 8 µm from the dish surface, and the respiration image (3D contour plot, Figure 5.8b) raster 
115 
 
shows the lowest respiration activity in the middle of the cell surface, and the highest respiration 
activity at the edge of the cell, where the cell makes contact with the Petri dish.  While this image 
does certainly have a component that comes from the distribution of the oxygen around the cell, it 
is obvious that we were able to record the oxygen depletion by the cell.  Figures 5.8c and 5.8d are 
the corresponding plots for topography (Fig. 5.8a) and respiration (Fig. 5.8b) respectively, and we 
have inserted crosshairs to better illustrate portions of the 2D profiles.  Figure 5.8c, which uses an 
external redox mediator and so is independent of physiological activity, shows a clear dependence 
between the current profile and topography for a roughly spheroid cell.  Figure 5.8d, however, 
displays a more convoluted oxygen profile that cannot be explained solely by topography, and 
therefore is indicative of physiological activity (i.e., respiration) and/or transport properties of the 
cell or membrane itself.  
 
 
Figure 5.9;  Images of stained mitochondria in (a) differentiated and (b) undifferentiated PC12 cells showing 
their location surrounding the nucleus, which appears as a darkened spot (arrows in (b) point to a clustering of 
mitochondria with the endoplasmic reticulum), while (c) is the respiratory profile of a single PC12 cell presented 
previously in Fig. 5.8b/d, with the false color spectrum adjusted to show high oxygen (absence of respiration) as 
black and low oxygen (respiratory activity) as bright green.  The locations ascribed to respiratory activity thus 
coincide with the locations where mitochondria are present in (a) and (b). [Mitochondrial images from Darios53]. 
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One could argue that the reason we are not observing uniform oxygen diffusion across 
the cell membrane is due to the higher distribution of mitochondria (where cellular respiratory 
activity occurs) at the points where the cell makes contact with the Petri dish substrate.  Previous 
work using fluorescence microscopy53 has shown that in cultured PC12 cells the mitochondria are 
predominantly located in these locations, rather than atop the cell nucleus, as shown in Figs. 5.9 
(a) and (b).  In order to illustrate the point effectively, the respiratory profile for the single PC12 
cell presented previously in Figs. 5.8b/d is shown again in Fig. 5.9c.  This time, however, the 
false color profile has been adjusted in order to mimic the mitochondrial stain used in Figs. 
5.9a/b.  Now the areas of the image corresponding to background oxygen levels (i.e., no 
respiration) are shown in black, while areas where reduced oxygen (i.e., respiratory activity) was 
detected are shown in bright green.  Comparison of Figs. 5.9a/b and c show that the areas within 
the cell where respiratory activity was detected (Fig. 5.9c) coincide with those where 
mitochondria are present (in Figs. 5.9a/b).  There is a slight ‘bleeding’ of green outside the area of 
the cell due to the depletion of oxygen in the surrounding media, which is also driven by cellular 
respiration. 
 
Conclusions 
We have manufactured enzyme UMEs for SECM use in the detection of lactate and 
glucose.  We have calibrated these sensors with respect to their analyte and we have shown for 
the first time that enzyme-based UMEs can be used for positioning the SECM tip via 
amperometric ACs with respect to the substrate to be scanned.  By employing the GOx- and LOx-
based UME biosensors, we have obtained glucose uptake and lactate release profiles for single 
cancer cells as a proof of concept for the application of SECM toward the study of basic 
metabolic processes that are affected by disease in cancerous cells.  We have also shown that 
respiration studies performed at closer tip-substrate separations (< 10 µm) reveal a non-uniform 
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distribution of oxygen that cannot be explained by the cell topography alone; these oxygen uptake 
profiles could give a more complete metabolic picture of the single cancer cells.  Comparison of 
this data with that from previously published mitochondrial staining of PC12 cells shows that the 
areas where respiratory activity was detected within the cell coincide with those populated by 
mitochondria.  Further experimentation, however, should be performed to definitively assign this 
convoluted oxygen uptake distribution to mitochondrial location alone.  The ability to look at 
single cell lactate production, glucose and oxygen consumption, in addition to previously 
published acidification rates profiles, will provide for a direct comparison of single cell data to 
our multi-cell data from MAMP experiments. 
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CHAPTER VI 
 
SECM IMAGING OF ANALOG ION CHANNELS* 
 
Introduction 
The non-invasive investigation of biological systems, especially at the single-cell level, 
continues to present a challenge to analytical chemistry.  The ability of electrochemical methods 
of analysis to meet this need has advanced in tandem with the state of the art in electrode 
construction.  The early adaptation of carbon electrodes1,2 provided the initial investigators with a 
rudimentary tool to conduct measurements on biological systems, but it was not until the 
implementation of the modern carbon fiber ultramicroelectrode3 (Cf-UME) that such 
measurements could be performed without considerable disturbance to the subject.  The 
subsequent development of scanning electrochemical microscopy4,5 (SECM) allowed for spatial 
as well as temporal differentiation of data, providing a new and powerful platform for the use of 
UMEs in the exploration of biological systems. 
 The ability of SECM to perform evaluations of biological systems was demonstrated 
shortly after its inception.6  Its ability to obtain spatio-temporal maps of both chemical activity 
and electrical conductivity in an non-invasive manner prevents the addition of uncertainty 
accompanied by the breeching of the cell membrane (as in patch-clamping) or the addition of 
extraneous functional groups (such as fluorescent tags) that can potentially alter physiological 
activity.  Through the use of a naturally occurring redox couple (e.g., catecholamine release by 
vesicles),7 SECM has the potential to generate completely non-invasive maps of biological 
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activity in live cultured cells.  Other prior biological applications of SECM include the 
determination of the ionic flux through synthetic pores (such as mica) or macro-scale biological 
membranes (such as dentine or skin),8-10 the biological activity of single cells,11-13 including the 
redox and acid-base reactivity of human cells14 and bacteria,15 the differences of reactivity 
between non-metastatic and metastatic human breast cells,16 and mapping of the morphology of 
neuronal analog cell lines.17,18  The ability of SECM to create spatial analyte concentration 
profiles has led to its adaptation in the measurement of metabolic rates, such as respiration in 
bovine embryos,11 peroxidase activity of algal protoplasts,19 and to study the permeability of the 
nuclear envelope of Xenopus laevis oocytes.20  SECM has also been utilized in the study of 
charge transfer through bilayer lipid membranes (BLMs),21 catecholamine emission during 
exocytosis,22 and NO emissions by human umbilical cells,23 but only to position a probe for 
stationary amperometric measurements; therefore no spatially resolved data was obtained. 
 Due to the complexity of biological systems, initial analyses often take place on more 
simple analog systems in order to avoid the myriad of interferents present in a living organism.  
When dealing with cellular signaling systems, more specifically with ion channels, α-helical 
peptides that form homo-oligomeric pores through BLMs are often employed as analog systems.  
Alamethicin, a member of the peptaibol family of antibiotics first isolated from Trichoderma 
Viride, has seen wide use as such a model.  Mueller and Rudin24 first reported that alamethicin 
could trigger ion transport in reconstituted lipid membranes, effectively mimicking the 
neurological action potential.  Alamethicin has since become one of the most studied ion channel 
mimics25 due to its ability to form homo-oligomeric channels, voltage-dependent conductance,26 
and its structural similarity to native transmembrane proteins.   
 We have incorporated alamethicin into phosphatidylcholine  BLMs in order to explore 
the capability of SECM to map ion channel flux in real-time.  The BLM is suspended horizontally 
in a two compartment electrochemical cell.  The probe tip, set to the redox potential of the 
analyte, is rastered across the surface and current measurements are recorded as a function of 
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position in the x and y directions, yielding a concentration profile map of the species traveling 
through the alamethicin pore.   Unlike previous applications of SECM to BLM studies, where the 
instrument was only used to position an electrode for stationary measurements, in this work we 
expand the focus to utilize the spatial capabilities of SECM as well.  Spatio-temporal imaging 
was applied toward the analysis of both passive transport (leakage) and active transport (through 
open pores) across BLMs. These images successfully demonstrate the ability of SECM to monitor 
voltage controlled transport through alamethicin pores embedded in reconstituted BLMs. 
 
Experimental 
Materials 
All materials listed in this section were used as supplied unless otherwise specified.  KCl 
(ACS grade), MeOH (bioreagent grade), and chloroform (ACS grade) were purchased from 
Fisher Scientific.  NaOH was ordered from EM Science, ethanol (absolute proof) from Aaper, 
ruthenium (III) hexammine (Ru(NH3)6Cl3, hereafter called Ru-hex) and 4-(2-hydroxyethyl)-1-
piperazine ethane-sulfonic acid (HEPES) were obtained from Acros Organics, n-decane (99%) 
was obtained from Alfa Aesar.  Alamethicin (from Trichoderma Viride) was obtained from 
Sigma-Aldrich as a solid, subsequently dissolved in EtOH and stored at 4 °C until further use.  
Ferrocenylmethyltrimethylammonium hexafluorophosphate (FcTMA . PF6, or FcTMA) was 
prepared according to the literature method.27  All electrolyte solutions used during imaging and 
formation of the BLM were filtered through a syringe-type filter (0.2 µm, Fisher Science) 
immediately prior to use. 
 L-α-phosphatidylcholine (p-choline, from chicken eggs) was received from Avanti 
Lipids dispersed in chloroform.  As per Avanti’s recommendations,28 the chloroform was 
evaporated by blowing a slow stream of nitrogen over the open vial, while holding it in the hands 
to keep it warm, until all visible liquid had evaporated and then placed under vacuum for an hour.   
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Once all chloroform was removed, the lipids were then re-dispersed in n-decane and kept at – 20 
°C until used.  All aqueous solutions were prepared using ASTM type I water (18 MΩ·cm-1, 
hereafter referred to as DI water) from a Solution 2000 (Aqua Solutions, Inc.) reverse osmosis 
system. 
 
Electrode Preparation 
The UMEs utilized in this study are of the disc-sealed-in-glass type, and were fabricated 
from 7 µm carbon-fibers (supplied by Dr. Aurelio Galli, Vanderbilt University Department of 
Molecular Physiology and Biophysics) with RG values of 1.4 (±0.1).  The UMEs were fabricated 
by the procedure published by Fan and Demaille for disk-in-glass UMEs,29 using 2 mm 
borosilicate glass capillaries, conductive silver epoxy from Epoxy Technology, 22-gauge generic 
copper hook-up wire, and white epoxy sealant (Hysol Epoxi-Patch) from Dexter Corporation.  
Ag/AgCl reference electrodes were obtained from CH Instruments, and counter electrodes were 
made of Pt wire (Goodfellow).   
 The electrode geometry for some UMEs utilized in this study was observed to deviate 
from that of a circular disc due to variations in the angle between the carbon-fiber and the wall of 
the capillary.  If the fiber was not parallel to the capillary, the resulting exposed disc was oval 
rather than round, and therefore had a higher surface area.  It is for this reason that steady state 
currents reported in some Fig. captions (Figs 4 & supplemental Fig. S2) exceed that expected for 
a 7 µm electrode in 1 mM Fc-TMA solution.  
 
Bilayer Membrane Imaging Cell 
A horizontal BLM cell (Fig. 6.1a) was designed based on previous work by Amemiya 
and Bard.30  The cell consists of two independently accessible chambers separated by a reinforced 
Teflon foil substrate incorporating the aperture for forming the BLM.  The Teflon foil septa 
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Figure 6.1;  (a) a schematic of the cell used for SECM imaging of BLMs in the horizontal configuration, based 
on work by Amemiya & Bard.30  (b)  a schematic of the simple cell constructed from a 35 mm cell culture dish to 
form horizontal BLMs. 
 
(model TP-01) were obtained from Eastern Scientific, LLC.  Each septum was 25 mm square and 
25 µm thick with a preformed, symmetrical aperture of 100 (± 25)µm.  These septa were glued 
with vacuum grease (Dow Corning) to a reinforcing plate for support, cut from the bottom of a 
plastic cell culture dish, with a hole drilled to allow access to both sides of the aperture (Fig 6.1b).    
During imaging, the species to be transported initially exists exclusively in the trans 
compartment, and detection occurs at the probe tip in the cis compartment.  
 
Bilayer Membrane Preparation 
Bilayer lipid membranes were made according to a technique  previously published by 
Tripathy et. al,31 which was adapted for use with horizontal BLMs.  This method was found to 
yield BLMs with a higher success rate, longer lifetimes, and less residual solvent content (i.e., a 
smaller annulus region) than the traditional paintbrush technique.  Prior to BLM formation, the 
Teflon foil septum and plastic plate were rinsed thoroughly in ethanol and DI water.  If any stains 
were visible on either the foil or the Teflon cell, they were soaked overnight in a base bath (EtOH 
saturated with KOH).  The foil septum and plate (hereafter referred jointly to as the BLM 
substrate) were glued together with high vacuum grease, and then rinsed again briefly with 
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ethanol and DI water.  The inside of the aperture was then ‘primed’ with a lipid/decane solution 
(25 - 40 mg/ml) using a trimmed sable or camel hair brush.  A slow stream of nitrogen was used 
to dry the lipid in the aperture.   
 Horizontal formation of the BLM was accomplished in a simple one-chamber cell (see 
Fig. 6.1b) constructed from a 35 mm cell culture dish.  A one-chamber design, in addition to its 
simplicity, prevents BLM rupture due to the unequal hydrostatic pressures on either side of the 
aperture that is possible in a two chamber system.  A thin spacer (made from a cut plastic 
washer), glued to the bottom of the dish with vacuum grease, allowed the solution access to both 
sides of the aperture, and permitted BLM formation.  A small amount of grease was applied to the 
top of the washer as well to hold the substrate in place during formation. The assembled cell was 
filled with either a KCl solution (0.1 – 1 M) or a buffer solution (0.1 M KCl and 0.01 M HEPES, 
pH 7.0).  Once the substrate was assembled, rinsed, primed, and dried, it was immediately 
submerged and affixed to the spacer in the dish.  The dish was then placed under a microscope to 
visually follow the remainder of the procedure.  A Drummond micropipette was filled via 
capillary force with the decane lipid solution, and then the bulk of the solution was expelled from 
the pipette (some residual lipid and solution remained adsorbed to its inner walls).   The pipette 
tip was then immersed in the solution immediately above the aperture of the substrate, and by 
squeezing the bulb of the pipette gently an air bubble was blown, forcing the remaining lipids 
from the pipette to the wall of the air/solution barrier of the bubble.  The bubble was then dragged 
(or ‘smeared’) across the aperture, leaving behind sufficient lipid to bridge the hole.  The lipid 
then spontaneously thinned to form a bilayer within 1-5 minutes.  After waiting ~5 minutes for 
the bilayer to stabilize, the BLM substrate was transferred to the BLM cell (see Fig. 6.1a) for 
imaging.   
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Pore Insertion 
Alamethicin pore insertion was performed by addition of ethanolic alamethicin (sufficient 
to render a final concentration of 100 ng ·  ml-1 in the cis chamber) via micropipette to the solution 
directly above the BLM.  After equilibration (~ 5 minutes), a potential of + 50 mV was applied 
across the membrane between the second working electrode (Ag/AgCl), which was placed into 
the trans chamber, and the reference electrode in the cis chamber (see Fig. 6.1a).   
 
SECM Imaging 
SECM experiments were conducted on a commercial instrument (CH instruments model 
900), controlled with proprietary software. To perform SECM imaging, the BLM cell (see section 
2.3) was assembled with the lower chamber filled with Ru-hex solution (1-5 mM in 0.1 M KCl 
and 0.01 M HEPES, pH 7.0) and the upper chamber with Fc-TMA (1 mM in 0.1 M KCl and 0.01 
M HEPES, pH 7.0).  All imaging was performed in the constant height mode, at a probe speed of 
12.5 µm s-1. Probe approach was performed via negative feedback utilizing the redox mediator in 
the cis compartment (FcTMA).   
 Since the BLM cell precluded the use of an inverted microscope during imaging, the 
aperture and BLM were initially located via topographical imaging prior to imaging of transport 
across the membrane (see Supplemental Information – Fig. S1).  In all cases, Fc-TMA was used 
as a topographical redox mediator while Ru-hex was used as the transported mediator.  Once the 
aperture and BLM were located, preliminary Ru-hex transport images of the BLMs (prior to 
addition of alamethicin) were obtained in order to verify the overall integrity of the membrane 
and allow evaluation of the levels of passive transport.  Membranes with pinpoint defects were 
easily detected via preliminary SECM imaging, due to the presence of ‘hot spots’ of flux in the 
region of the defect.   
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Figure 6.2;  (a) topographical schematic cross-section of a BLM/aperture (not to scale) illustrating the difference 
in thickness between the BLM and the teflon aperture, (b) an optical microscopy image of a BLM formed in a 
teflon septum with aperture of 100 µm diameter, (c) SECM image showing increased passive transport through 
a BLM in the annulus region [7 µm CF-UME, 1 mM Ru-hex, 0.1 M KCl, 0.01 M HEPES, pH 7.0, E = -0.35 V, 
iss(Fc-TMA,1mM) = 1.2 nA]. 
 
Results and Discussion 
In order to discuss the results of the experiments, it is first helpful to understand the 
mechanism of formation and the resulting topography of the BLMs formed in these experiments.  
The formation of the BLM itself, via a decane film suspended in aqueous solution, is thought to 
occur via a mechanism similar to the closing of a zipper,32 as the tails of the two opposing 
monolayers intercalate to form the bilayer.  When followed via optical microscopy, the process 
can be seen to begin with the appearance of a single dark spot where the two monolayers initially 
meet.  The spot rapidly grows outward toward the edges of the aperture, with the BLM becoming 
opaque as it stabilizes.  The bilayer is prevented, however, from extending completely to the 
edges of the aperture due to the difference in thickness (Fig. 6.2a) between the BLM (~10 nm) 
and septum (~25 µm).  The Plateau-Gibbs border, present at the edges of the bilayer, is then 
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visible in transmission optical microscopy images (Fig. 6.2b) as a translucent ring between the 
aperture egde (seen in the image as a darkened ring) and the completely opaque central bilayer.  
Due to this ring-like appearance it is often referred to as the annulus.  In the annulus region, as 
opposed to the center, the bilayer is thought to undergo a transition, becoming essentially two 
monolayers separated by pocket of trapped decane (see Fig. 6.2a).  Due to this trapped solvent, 
the annulus would be expected to pose less resistance than the central region of the BLM to the 
mass transport of a cation such as Ru-hex.   
 SECM, due to its ability to map both topography and mass transport across the BLM, was 
employed to determine if such differences could be detected.  SECM images of Ru-hex transport 
taken in the absence of alamethicin (Fig. 6.2c) show a slight leakage current around the outer 
edges of the BLM.  The difference in current detected between the teflon septum (green) and the 
BLM (blue) can be explained by noting that the BLM is recessed in the aperture (Fig. 6.2a), 
rather than at the same level as the teflon surface. Since larger tip-substrate separations when the 
probe is positioned over the BLM result in higher negative-feedback currents, the current over the 
BLM is greater than that over the subtrate.  The difference in width of the annulus in the SECM 
image (region of higher current in Fig. 6.2c) as opposed to the optical image (Fig. 6.2b) is thought 
to be due to lateral diffusion of the Ru-hex prior to reaching the probe tip.  The lack of leakage on 
the left side of the annulus in Fig. 6.2c is an artifact resulting from the direction and speed of the 
probe scan during the experiment.  Since the instrument utilizes the fastest possible rate for the 
return of the probe to the x-axis origin (the left side of the image) after each line-scan, a localized 
convection in the solution persists for a short time which disturbs the mass transport between the 
annulus and the probe tip.  When the direction of probe travel was reversed (not shown), the 
resulting image showed the same absence of leakage on the right side of the BLM instead of the 
left. Additionally, no difference in transport current is detectable between the annulus region and 
the remainder of the BLM at higher scan rates, again suggesting that high probe speed leads to 
convection within the solution. 
129 
 
 Since the irregular geometry of the aperture opening caused problems during SECM 
approach, probe approaches were performed at the higher septum surface, far from the aperture.  
Due to the taper of the aperture, the BLM surface is much lower (farther from the probe tip) than 
the septum surface, allowing the Ru-hex to diffuse laterally and creating the anomaly of a wider 
surface area.  The tip-septum distance for this image was extremely small, as can be seen by the 
level of background current (in the pA range).  Images taken at greater probe-septum separation 
were less likely to show differences between the annulus blockage and that of the BLM itself, 
also perhaps due to lateral diffusion prior to reaching the probe tip.  
 
 
Figure 6.3;  SECM image of the Ru-hex leakage (passive transport) through a pinpoint defect in a BLM.  [7 µm 
CF-UME, 1 mM Ru-hex, 0.1 M KCl, 0.01 M HEPES, pH 7.0, E = – 0.35 V, iss(Fc-TMA, 1 mM) = 1.0 nA]. 
 
 SECM analyses also proved useful in the preliminary evaluation of the integrity of the 
BLMs formed during the course of this experiment.  While optical microscopy is useful in 
determining whether a BLM is present, or if formation is not yet complete, it has only limited use 
in its ability to evaluate the overall integrity of the membrane formed.  Some pinpoint defects 
(Fig. 6.3), for example, were not readily visible during examination of optical images, but were 
easily detected by preliminary SECM imaging of membrane transport.   
 Upon addition to the solution surrounding a BLM, alamethicin is thought to form a pore 
via a voltage-dependent barrel-stave mechanism,26 where the α-helices initially adsorb parallel to 
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the lipid membrane.  Only upon application of a sufficient membrane potential (50 mV) do the 
helices incorporate themselves into the membrane and assemble to form an active pore.26 To 
ensure that the current measured after alamethicin insertion was the product of mass transport 
through an active pore, and not electroporation (degradation due to an applied potential), control 
experiments were performed by applying the bias across a fresh BLM (not shown).  There was no 
change in the BLMs resistivity as a result of the applied bias.   
 
 
Figure 6.4;  SECM images taken sequentially showing the transport of Ru-hex through the same BLM prior to 
addition of alamethicin (a), after addition of alamethicin but without application of a membrane bias (b), and 
with a + 50 mV membrane bias (see section 2.5) (c).  (a) and (b) share the same color scale (in pA), while (c) has 
its own color scale (in nA).  The current increase from prior to insertion (b) to after insertion (c) is over one 
order of magnitude (from 150 pA to 3.1 nA).  [7 µm CF-UME, 1 mM Ru-hex, 0.1 M KCl, 0.01 M HEPES, pH 
7.0, E = – 0.35 V, iss(Fc-TMA, 1 mM) = 1.9 nA]. 
 
 Once the integrity of the reconstituted BLM was verified by preliminary imaging, 
alamethicin pores were incorporated into the membranes.   SECM images of mass transport 
through a BLM in the course of a pore insertion experiment can be seen in Figs. 6.4a-c.  The first 
SECM image (Fig. 6.4a) displays the blocking BLM (in green) and the surrounding teflon septum 
(in white) prior to the additon of alamethicin to the cell.  When the pore forming antibiotic was 
added via micropipette to the cis compartment, a second image of the same BLM (Fig. 6.4b) was 
recorded, with no membrane bias. Fig. 6.4b demonstrates the inability of the alamethicin helices 
to insert themselves into a BLM in the absence of an applied membrane bias.  The currents 
detected prior to the addition of alamethicin (Fig. 6.4a) are similar to those in the SECM image 
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where alamethicin is present but a membrane bias is not (Fig. 6.4b).  Assembly of the 
reconstituted pore can be seen in the last image (Fig. 6.4c), where three separate ‘hot spots’ of 
Ru-hex transport were detected.  Due to lateral diffusion, it is not possible to tell whether each of 
the three individual areas of high current is due to one or several embedded pore bundles.  The 
result of the mass transport through the inserted pores is seen as an increase in detected current of 
well over one order of magnitude (from 150 pA to 3 nA).  
 Although the image (Fig. 6.4c) does not show the clear location of a single channel, this 
is hardly possible given the acquisition time (~ 25 minutes) of the experiment performed.  Lipid 
bilayers are fluid environments, and alamethicin pores are dynamic structures, therefore within 
the timescale of one imaging experiment a single given pore could change both location and size 
(e.g. vary the number of constituent monomers) many times.  While this image does not pinpoint 
the location of a single channel, it does provide a probability distribution over where one may be 
located at any given time. 
 The use of alamethicin pores as biological ion channel analogs has generally focused on 
their ability to reproduce voltage-gated channel activity.  There has also been a recent move 
toward the design of microfluidic switches and valves based on biological models.  Since the 
biological ion channel could be viewed as an ideally refined microfluidic bio-switch, it was 
decided to evaluate the ability of its analog system (the alamethicin pore) to behave in that 
capacity.  Of main concern was whether the difference between the currents measurable in the 
open and closed conformations would be sufficient to be able to detect a change in states from 
open to closed (or vice versa).  
The results of modulating the membrane potential are shown in Figs. 6.5a-c.  The first image 
(Fig. 6.5a) is the BLM prior to insertion of the alamethicin, and due to the lower current it has a 
color scale (with current in nA) distinct from the other two images.  The result of pore insertion, 
due to the initial application of a membrane bias (50 mV), can be seen by the increase 
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Figure 6.5;  Sequential SECM images showing the same BLM prior to insertion of an alamethicin pore (a), after 
insertion of the pore with a  50 mV membrane bias (see section 2.5) (b), and then after removing the bias (c).  
Images (b) and (c) share the same color scale (both scales in nA).  Once again insertion of the pore (b) results in 
an increase of transport current by over an order of magnitude.  The same color scale was utilized for (b) and (c) 
to compare the current resulting from the removal of the membrane bias (current decreases by ~ 50% from (b) 
to (c)).  [7 µm CF-UME, 1 mM Ru-hex, 0.1 M KCl, 0.01 M HEPES, pH 7.0, E = – 0.35 V, iss(Fc-TMA, 1 mM) = 
0.98 nA]. 
 
in current between the first image (Fig. 6.5a) and second (Fig. 6.5b).  The third image (Fig. 6.5c) 
was then taken after removal of the membrane potential.  The shared color scale (current also in 
nA) between the last two images enables the comparison between the current in the on (Fig. 6.5b) 
and off (Fig. 6.5c) states of the pore.  The current detected for the pore in closed conformation 
(Fig. 6.5c) shows a drop in current of ~ 50% from the open state (Fig. 6.4b).  The image of mass 
transport in the closed conformation (Fig. 6.5c) retains, however, the spatial distribution found in 
the open conformation (Fig. 6.5b) suggesting that the alamethicin pores are retained in the 
membrane even in the absence of a membrane potential.  This successfully demonstrated voltage-
gated control of the flux across the BLM through the alamethicin pores. 
 
Conclusions 
An analog of a biological ion channel system was assembled utilizing a decane dispersion 
of p-choline to form a planar BLM in a 100 µm diameter aperture, into which was inserted the 
antibiotic porin alamethicin.  SECM, in the constant-height mode was utilized to measure mass 
transport of Ru-hex under various conditions.  Utilization of SECM enabled the evaluation of 
overall BLM integrity, verification of pore insertion, and control of the mass transport of ions 
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through the membrane.  SECM images showed that the annulus region (Plateau-Gibbs border) of 
the BLM posed a lower resistance to passive transport of the Ru-hex cation through the 
membrane.  The insertion of alamethicin, and subsequent pore formation, was confirmed by an 
increase in the measured current levels by more than one order of magnitude over the background 
(leakage) values due to the mass transport of Ru-hex from the trans compartment.  Additionally, 
the removal of the membrane bias resulted in a detectable change in the current resulting from 
mass transport, suggesting the possibility that the system could be used as a reversible switch or 
microfluidic valve.  
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APPENDIX A 
 
BIOFOULING 
 
 One of the major recurring problems occurring in electroanalytical chemistry, and one 
that becomes more predominant in biological analyses, is that of electrode fouling.1-3  In 
unmodified electrodes all chemical reactions occur directly on the surface of the electrode itself, 
in a rapid sequence of adsorption/reaction/desorption steps.  Any substance adhering to the 
electrode surface, therefore, will result in a reduction of the surface area available to drive such 
reactions.  In real samples, especially biological ones, there are substances within the sample 
matrix itself that are capable of blocking the electrode.  In other cases, the fouling species can be 
generated by oxidation of a species in the matrix, including the analyte itself.1 
 Biofouling, or electrode fouling due to biological material, is even more predominate 
with the use of micro and ultramicroelectrodes, due to differences in diffusion and the reduced 
surface areas involved.  With micro electrodes the increased sensitivity toward electrode fouling 
is solely due to a decrease in surface area, but in ultramicroelectrodes there is an additional 
diffusional contribution.  In macro and micro electrodes, the analytes diffuse toward the electrode 
surface linearly (fig. A.1a).  In ultramicroelectrodes, however, the diffusional pattern is more 
spherical, due to the extremely smaller electrode area (fig. A.1b).  In this case, there is a higher 
analyte flux per unit of surface area, and any reduction in surface area will have a larger 
corresponding reduction in current response, and will occur typically in a shorter amount of time. 
There are three possible strategies frequently implemented to prevent and/or minimize 
electrode fouling within the sensor design itself.  The first option is to use electrode materials that 
inherently have lower potential for biofouling, such as carbon nanotubes or more recently doped 
diamond electrodes.4-6 This is the best choice when while designing a sensor system you 
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Figure A.1; The diffusional migration of redox species to (a) ultramicroelectrode and (b) micro/macro electrode 
surfaces.   
 
anticipate there may be a potential for biofouling, however for other pre-existing electrode 
systems there are other measures that can be taken as well.  A second strategy, as utilized by 
Davies and Brenk7 and later by Clark8,9 for unmodified electrode surfaces, is to limit or eliminate 
the ability of unwanted substances from reaching the electrode surface.  This is done through 
incorporation of permselective membranes10,11, self-assembled monolayers,12 or films to the 
electrode.2,13-15  The third strategy is to modify the electrode surface itself to reduce adhesion of 
the poisoning agents.  This is done by deposition of metallic films or the inclusion of resistant 
materials such as carbon nanotubes or chitosan into film coatings.  The choice of which strategy 
to follow depends on individual situations. 
 In addition to changes in sensor design, there are also changes in experimental design that 
can be implemented to minimize biofouling.  If the fouling is a result of the electrode reaction 
itself, a switch from constant-potential amperometry to square-wave amperometry or even cyclic 
voltammetry can reduce the extent of biofouling by minimizing the amount of time current is 
passed through the electrode.  This will, however, decrease temporal resolution of the data 
collected.  This may also be supplemented by the application of a potential pulse between 
measurements which in some cases has been shown to reverse the effects of unwanted adsorbed 
substances.  Most recently, this potential pulse conditioning has been utilized in condition with 
thermal conditioning to re-activate the surface of a fouled electrode.1  This strategy, however, 
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would not be feasible in the proximity of live cells due to the potential for damage to the cells 
themselves. 
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APPENDIX B 
 
RESULTS OF STATISTICAL ANALYSIS ON ORGANOPHOSPHATE DATA 
 
Table 1;  Statistical analysis of OP experimental results reported in Chapter 3.  F-tests and t-tests for all 
analytes, at each exposure level, show that differences in means and variances (with respect to the RPMI 
control) are significant at the 95% confidence level. 
RPMI 1 µM 10 µM 100 µM 500 µM 1 mM 
D
o
pa
m
in
e 
 
mean 11.885 29.352 35.483 47.383 33.002 30.573 
standard deviation 2.077 6.587 9.960 9.640 4.626 2.325 
n 16 16 17 14 13 13 
degrees of freedom 
 
30 31 28 27 27 
t exp 
 
10.607 9.769 13.777 16.456 28.984 
t crit (@ 95%) 
 
1.7 1.7 1.7 1.7 1.7 
F 
 
8.801 53.556 21.189 11.116 8.300 
F crit 
 
4.210 4.225 4.242 4.260 4.242 
Ca
lc
iu
m
 
 
mean 2.614 3.676 4.638 4.063 3.598 3.769 
standard deviation 0.455 1.221 0.901 1.046 0.963 1.376 
n 13 16 15 14 13 14 
degrees of freedom 
 
27 26 25 24 25 
t exp 
 
3.481 8.700 5.185 3.688 3.142 
t crit (@ 95%) 
 
1.7 1.71 1.71 1.71 1.71 
F 
 
33.323 35.578 88.627 51.119 98.696 
F crit 
 
4.121 4.139 4.139 4.160 4.149 
G
lu
c
o
se
 
mean 93.987 54.205 46.100 30.000 37.525 23.721 
standard deviation 21.153 20.575 26.362 18.058 23.682 18.977 
n 20 17 15 15 13 14 
degrees of freedom 
 
35 33 33 31 32 
t exp 
 
7.972 7.035 13.723 8.596 13.854 
t crit (@ 95%) 
 
1.69 1.7 1.7 1.7 1.7 
F 
 
109.083 81.484 206.963 268.524 521.958 
F crit 
 
4.160 4.171 4.196 4.210 4.210 
La
c
ta
te
 
 
mean 0.475 0.996 0.869 0.836 0.404 0.323 
standard deviation 0.105 0.120 0.104 0.142 0.106 0.083 
n 17 10 14 15 14 12 
degrees of freedom 
 
25 29 30 29 27 
t exp 
 
13.753 14.222 9.854 2.495 6.381 
t crit (@ 95%) 
 
1.71 1.7 1.7 1.7 1.7 
F 
 
140.451 109.716 68.224 3.473 17.650 
F crit 
 
4.242 4.183 4.171 4.183 4.210 
141 
 
Table 2;  Statistical analysis of OP experimental results reported in Chapter 3.  F-tests and t-tests for dopamine, 
glucose and lactate, at each exposure level, show that differences in means and variances (with respect to the 
DMSO control) are significant at the 95% confidence level.  F-test and t-test results for calcium, however, 
indicate that only results for 10 and 100 µM are significant at the 95% level (data failing significance testing is 
highlighted in red). 
DMSO 1 µM 10 µM 100 µM 500 µM 1 mM 
D
o
pa
m
in
e 
 
mean 15.236 29.352 35.483 47.383 33.002 30.573 
standard deviation 4.643 6.587 9.960 9.640 4.626 2.325 
n 24 16 17 14 13 13 
degrees of freedom   38 39 36 35 35 
t exp   8.572 8.382 12.477 13.845 23.787 
t crit (@ 95%)   1.69 1.69 1.69 1.69 1.69 
F   67.154 69.988 187.104 121.914 109.609 
F crit   4.098 4.105 4.121 4.13 4.149 
Ca
lc
iu
m
 
 
mean 3.357 3.676 4.638 4.063 3.598 3.769 
standard deviation 0.675 1.221 0.901 1.046 0.963 1.376 
n 22 16 15 14 13 14 
degrees of freedom   47 46 45 44 45 
t exp   1.046 5.505 2.526 0.904 1.120 
t crit (@ 95%)   1.68 1.68 1.68 1.68 1.68 
F   1.064 24.462 6.096 0.759 1.443 
F crit   4.113 4.12 4.13 4.139 4.13 
G
lu
co
se
 
mean 64.961 54.205 46.100 30.000 37.525 23.721 
standard deviation 23.856 20.575 26.362 18.058 23.682 18.977 
n 24 17 15 15 13 14 
degrees of freedom   39 37 37 35 36 
t exp   12.679 9.294 13.568 9.631 12.473 
t crit (@ 95%)   1.69 1.69 1.69 1.69 1.69 
F   5.324 5.324 23.645 11.209 30.464 
F crit   4.105 4.105 4.105 4.121 4.113 
La
ct
a
te
 
 
mean 0.593833 0.996 0.869 0.836 0.404 0.323 
standard deviation 0.216421 0.120 0.104 0.142 0.106 0.083 
n 24 10 14 15 14 12 
degrees of freedom   32 36 37 36 34 
t exp   10.618 9.932 6.615 6.674 11.346 
t crit (@ 95%)   1.7 1.69 1.69 1.69 1.7 
F   30.257 19.751 14.754 9.337 17.347 
F crit   4.149 4.113 4.105 4.113 4.13 
 
